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Abstract	  	  
Malaria infection caused by the apicomplexa pathogen Plasmodium falciparum has a high 
rate of resistance to existing anti-malarial drugs. The World Health Organisation 
recommended interventions are unlikely to eliminate the growth of resistance and it would 
therefore be prudent to continue the search for new drug targets for the continued 
combatting of malaria. 
Plasmodium falciparum is parasitic on the host for its metabolites and therefore inhibiting 
the transportation of glutamine from the host, has long been considered a potential strategy 
for combating the spread of infection. The recently sequenced Plasmodium falciparum 
genome has however shown that pathways for independent survival are also conserved. 
Therefore, combating the spread of Plasmodium falciparum in the human host, in addition 
to inhibiting the transportation of glutamine, will also require the inhibition of the de novo 
expression of essential amino acids within the Plasmodium falciparum cell. This could be 
achieved by inhibiting the glutamine synthetase gene, which is an essential step in the 
tri-carboxylic acid cycle. 
The adenine and thymine rich Plasmodium falciparum glutamine synthetase gene was 
codon optimized for expression in Escherichia coli. Soluble over-expression was achieved 
by cold-shock expression with vector pCold I (Takara) in Escherichia coli (DE3).  A hexa-
histidine tag enabled a single step Ni-affinity chromatography purification that produced a 
homogenous, catalytically active enzyme. 
Electron microscopy showed the glutamine synthetase of Plasmodium falciparum 
monomer forms two 6-fold symmetric rings that stack back-to-back with dihedral 
symmetry. An atomic model was built based on the homology with type I glutamine 
synthetases of known structure. This model indicated conservation of the structure with 
type I glutamine synthetase and locates a sequence insertion of 39 amino acids in the outer 
surface of the dodecamer.  
The study successfully expressed soluble Plasmodium falciparum glutamine synthetase. A 
negative stained 3-D reconstruction confirmed that the protocol used for the purification of 
Plasmodium falciparum glutamine synthetase, produced a homogenous dodecamer 
enzyme, hence paving the way for further structural studies.  
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Chapter	  1	  –	 Introduction	  
1  
Malarial infection is caused by Plasmodium. Five species infect humans, namely 
falciparum, vivax, ovale, knowlesi and malariae, of which Plasmodium falciparum is the 
severest form and is responsible for almost all deaths. Many of the current drugs for the 
treatment of malaria are already ineffective in many regions of the world and Plasmodium 
falciparum induced malaria, can only be treated by Artemisinin-based combination 
therapies (ACTs). Furthermore, the Thai-Cambodian border region has recently confirmed 
resistance to Artemisinin. The World Health Organisation (WHO) has implemented 
interventions in terms of treatment strategies, to reduce the spread of resistance before it is 
globalized (WHO, 2011). This is due to the high rate of resistance to previous antimalarial 
drugs. As a result, Dr Margaret Chan, Director-General of the WHO has stated “The threat 
must be taken seriously” (WHO, 2011, p.5). Hence, an extensive global accord has been 
reached to invest and to implement the WHO recommended interventions. However, it is 
likely the growth of resistance would be slowed but not entirely eliminated. It is therefore 
be prudent to use this window to identify potential new drug targets for the continued 
combatting of malaria. 
1.1 Dual	  Strategy	  for	  Combatting	  Spread	  of	  Malaria	  at	  Blood	  Stage	  
Plasmodium falciparum is parasitic on the host for its metabolites, however, it is also able 
to proliferate with only isoleucine provided in the growth media (Liu et al., 2006), which is 
indicative of having conserved  the pathways for independent survival (Payne & Loomis, 
2006). Completion of the Plasmodium falciparum genome shows the genes for the 
tricarboxylic acid cycle are conserved. Biochemical studies have indicated the metabolite, 
acetyl coenzyme A (acetyl-CoA), that normally activates the tricarboxylic acid cycle in the 
mitochondria, is absent in Plasmodium falciparum. Instead, the tricarboxylic acid cycle is 
activated by 2-ketoglutarate, generated from the intake of glutamine (Olszewski et al., 
2010). Therefore, combatting of the spread of Plasmodium falciparum in the human host 
will require more than simply inhibiting of the transport pathway for metabolites to enter 
the Plasmodium cell. In addition, the inhibition of the de novo expression of essential 
amino acids within the Plasmodium falciparum cell is also required.  
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1.2 The	  Role	  of	  Glutamine	  Synthetase	  in	  Nitrogen	  Metabolism	  
1.2.1 Nitrogen Assimilation 
In virtually all cellular activity, glutamate and glutamine serve as nitrogen-donors for 
biosynthetic reactions (Merrick & Edwards, 1995). Bacteria are able to scavenge numerous 
nitrogen compounds, but ammonia is considered to support the fastest growth rates 
(Reitzer, 2003). 
1.2.2 Ammonia assimilation in Bacteria 
Ammonia is assimilated into glutamine and glutamate by two major pathways - glutamine 
synthetase/glutamate synthetase (GS/GOGAT) pathway and the glutamate dehydrogenase 
(GDH) pathway.  
The GS/GOGAT pathway, being the more important and ubiquitous pathway in bacteria, 
results in the production of glutamate from ammonia and 2-ketoglutarate in bacteria, as 
depicted Figure 1.1 and 1.2 by each of the enzymatic reactions in the respective 
biosynthetic direction.  
 Figure 1.1    Bio-synthetic glutamine synthetase reaction of the GS/GOGAT pathway. Glutamate and 
ammonia with ATP yield glutamine, ADP and inorganic phosphate. 
 
Figure 1.2    Bio-synthetic glutamate synthase reaction of the GS/GOGAT pathway. Glutamine and 
2 ketoglutarate  with NADPH and H+ yield 2 Glutamate and NADP. 
These pathways are ubiquitous in bacteria and the contribution of each of the pathways in 
assimilating ammonia and hence, nitrogen transportation, may differ for each organism 
(Merrick & Edwards, 1995). In both Clostridium pasteurianum and Streptomyces 
clavuligerus ammonia assimilation occurs exclusively via the GS/GOGAT pathway 
(Dainty, 1972; Brana et al., 1986). On the other hand, ammonia assimilation occurs 
 3 
exclusively via the glutamine dehydrogenase pathway for Streptococcus bovis (Chen & 
Russell, 1989). The biosynthetic reaction for this pathway is indicated in Figure 1.3. 
 
Figure 1.3    Bio-synthetic GDH reaction. Ammonia and 2 ketoglutarate with NADPH and H+ yield 
Glutamate and NADP. 
Nitrogen requirements for the composition of nitrogen containing compounds essential to 
life are derived almost exclusively from glutamate and glutamine (Reitzer & Magasnik, 
1987), where: 
• Glutamate provides the alpha-amino group for synthesis of amino acids, half the 
nitrogen for pyrimidine, purine and imidazole rings. 
• Glutamine provides nitrogen for the synthesis of amino acids, p-aminobenzonate 
and NAD and the nitrogen for completing the formation of purines, pyrimidines, 
histidines and tryptophan (Wohlheuter et al., 1973) 
Extensive studies conducted on Escherichia coli indicate that, at high concentrations of 
ammonia in the environment, sufficient quantum is able to diffuse across the cytoplasmic 
membrane. This is required for proliferation, however, when diffusion becomes limiting, 
an ammonium transporter (AmtB) is synthetized (Burkovski, 2003). In the presence of 
high concentrations of ammonia, GS is suppressed and glutamate dehydrogenase is the 
primary pathway to assimilate ammonia. In the presence of low concentrations of ammonia 
(<1mM), the GS/GOGAT pathways dominate (Merrick & Edwards, 1995; Burkovski, 
2003). Therefore, in cells grown in nitrogen-limited media, glutamine synthetase is the 
dominant ammonia-assimilating enzyme.  
Targeting the inhibition of glutamine synthetase with glutamate analogues in plants, 
showed a rapid accumulation of ammonia and caused plant death. However, the inhibitors 
were found to be equally effective on weeds and crops (Logusch et al., 1991). This 
inability of the inhibitors used to distinguish between weeds and crops has resulted in 
limited use of glutamine synthetase inhibitors as a direct herbicide. Nevertheless, ongoing 
structural studies by Occhipinti et al., (2009) to identify selective glutamine synthetase 
inhibition remains an active research area. Similarly, the glutamate analogue, 
L-methionine-S-sulfoximine (MetSOx) was found to rapidly inactivate purified 
Mycobacterium tuberculosis glutamine synthetase, and was shown to block the growth of 
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the pathogen (Harth & Horwitz, 1999). Screening with ATP analogues for possible 
inhibition by irreversibly binding to the active site in glutamine synthetase is currently 
being pursued as a possible drug target for the Mycobacterium tuberculosis pathogen 
(Gising et al., 2012).  
1.2.3 Glutamine Synthetase  
As a result of the importance to nitrogen metabolism in bacteria, glutamine synthetase is 
the only known biosynthetic reaction to the formation of glutamine and has therefore been 
extensively studied and characterized (Brenchley et al., 1975; Fuchs & Keitster, 1980; 
Backman et al., 1981; Bhatnagar et al., 1986; Bohannon & Sonenshein, 1989; Fisher & 
Wray, 1989; Graziano Pesole et al., 1995). Glutamine synthetase is generally classified in 
four main classes, GS I, glnT, GS II, and GS III. To simplify discussion, it will be assumed 
that the glnT class is a subset of the GS I classification. 
The length of the monomer enables one to distinguish the family to which the glutamine 
synthetase belongs. The length of the three main classes mentioned above average 360, 
450, and 730 amino acids respectively. All glutamine synthetases are composed of two 
closed ring structures with the active sites formed between the protomers (Berman et al., 
2000).  
The physiologically relevant reaction arising from GS is the formation of glutamine as 
indicated in Figure 1.1 and 1.2. ATP first binds, followed by glutamate to form an 
intermediate γ-glutamyl phosphate and ADP. The ammonium ion then binds and attacks 
the intermediate γ-glutamyl phosphate to form glutamine and an inorganic phosphate 
(Liaw et al., 1995). ADP and the inorganic phosphate do not dissociate until the 
ammonium ion binds and the glutamine is released (Eisenberg et al., 2000).  
The regulatory mechanism for GS enzyme activity is not uniform and can vary between 
tissue types for the same organism (Merrick & Edwards, 1995). GS expression level is 
highly regulated by nitrogen starvation, which has been studied extensively in Escherichia 
coli. A further cascade regulatory system through the adenylylation and de-adenylylation 
of a tyrosine associated with each active site has also been extensively studied in 
Escherichia coli, but its allosteric impact of the active site remains largely unknown.  
1.2.4 Glutamine Synthetase Regulation  
Review on glutamine synthetase regulation by Woods and Reid, (1993) indicates there is 
no single regulatory mechanism at the transcriptional and post-transcriptional level. 
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Post-translational modifications also regulate glutamine synthetase activity. In most cases, 
glutamate synthetase enzyme is regulated in response to nitrogen but it appears that there 
are different regulatory mechanisms that ensure optimization of the use of nitrogen 
substrates.  
At least three post-transcriptional regulations of glutamine synthetase are well 
documented:  
• Adenylylation and subsequent de-adenylylation of a tyrosine residue, 
• Presence of divalent cation, Mg++ or  Mn++ , at the active sites, 
• Attachment of multiple end products of glutamine metabolism. 
1.2.4.1 Adenylylation inhibition of Glutamine Synthetase 
Glutamine synthetase obtained from nitrogen-starved cells is less sensitive to feedback 
inhibition than glutamine synthetase that is grown in a nitrogen-rich medium. This 
differential inhibition is the direct result of the covalent addition of an AMP moiety to a 
conserved tyrosine residue of each subunit of the glutamine synthetase enzyme (Woods & 
Reid, 1993). Once adenylylated, that specific subunit is inactive such that the enzyme can 
exist in a range of activity states within the cell (Stadtman, 2001). Adenylylation occurs in 
response to high nitrogen conditions, and progressive de-adenylylation occurs as nitrogen 
becomes more limiting, thereby activating the enzyme.  
The regulation of glutamine synthetase activity through adenylylation and de-adenylylation 
is accomplished by the interaction of three proteins:  
• uridylyltransferase / uridylyl-removing enzyme,  
• the signal transduction protein PII  
• and adenylytransferase  
Figure 1.4 depicts the complexity of this bicyclic cascade regulation of glutamine 
synthetase activity.  
 6 
 
Figure 1.4    Bi-cyclic cascade regulation of glutamine synthetase activity with 12 subunits. Inter-
relationship between the inter-conversion of the regulatory protein between uridylylated 
(PII-UMP) and unuridylylated (PII) forms, and the cyclic interconversion of GS between 
adenylylated (GS-AMP) and unadenylylated forms. ATa and ATd denote the 
adenylylation and de-adenylylation sites of adenylyltransferase, respectively; UTd and 
UTu denote the deuridylylation and uridylylation sites of uridylyltransferase, respectively. 
(Adapted from Merrick & Edwards, 1995) 
The enzymes catalysing the adenylylation and de-adenylylation reactions are also subject 
to fine metabolic control in themselves. A high intracellular concentration of glutamine 
activates the uridylyl-removing enzyme, which causes the de-uridylylation of the 
regulatory protein PII. This unmodified PII interacts with adenylyltransferase, which in turn 
catalyzes the adenylylation of glutamine synthetase, thus resulting in an inactive form of 
the glutamine synthetase subunit (Merrick & Edwards, 1995). 
Conversely, a high intracellular concentration of 2-ketoglutarate relative to glutamine 
activates uridylyltransferase, transfers a UMP group to each subunit of the regulatory 
protein PII to form PII-UMP. The interaction between adenylyltransferase and PII-UMP, 
then catalyses the removal of AMP from glutamine synthetase resulting in an active form 
of glutamine synthetase (Merrick & Edwards, 1995; Radchenko et al., 2013). 
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Not all glutamine synthetase enzymes, from the different organisms, have a conserved 
adenylylation loop and those organisms are therefore reliant on other regulatory 
mechanisms. 
1.2.4.2 Cation Mg++ / Mn++ attachment  
Abell et al., (1995) note that “the enzyme requires two divalent metal ions in each subunit 
for catalysis, which are distinguished from one another by their dissociation constants. The 
more tightly bound metal ion is required to keep the enzyme in its catalytically active 
conformation while the less tightly bound metal ion is thought to facilitate nucleotide 
binding”. In the review paper on structure-function relationships of glutamine synthetase 
Eisenberg et al., (2000) also note the importance of divalent metal ions (either Mg++ or 
Mn++) has been recognized for both activity and structural stability. Activity can vary 
depending on which divalent metal is bound (Mg++ or Mn++) to the enzyme, however, it is 
generally accepted that Mg++ is physiologically more prevalent. 
1.2.4.3 Feedback regulation 
Glutamine synthetase activity is subject to cumulative feedback inhibition by the products 
of glutamine metabolism. The adenylylated (active) form of glutamine synthetase is 
inhibited by alanine, glycine, histidine, tryptophan, CTP, AMP, carbamoyl phosphate and 
glucosamine-6phosphate (Reitzer, 2003). Each inhibitor was found to decrease glutamine 
synthetase activity partially so that the residual activity in the presence of several inhibitors 
equalled the product of the individual residual activities. This was interpreted as the result 
of each inhibitor acting/binding at a different site on the enzyme. Acting together, 
therefore, the feedback products were found to abolish activity.  
However, alanine, serine and glycine have been seen in crystal structures to bind to the 
glutamate substrate (S. Liaw, et al., 1993a; S. Liaw, et al., 1993b; S. Liaw et al., 1994; S. 
Liaw & Eisenberg, 1994). Similarly, GDP, ADP and AMP have been seen to bind to the 
ATP site by Eisenberg et al. (2000), suggesting that there may be a simpler mechanism for 
feedback control than that of cumulative inhibition from separate sites.  
1.2.4.4 Transcriptional regulation 
Woods and Reid (1993) elucidate the regulation of glutamine synthetase in a range of 
organisms from enterobacteriaceae (Escherichia coli, S. typhimurium and K.aerogenes) 
Bacillus subtilis, Clostridium acetobutylicum, Bacteriodes fragilis, Butyrivibro 
fibrisolvens, Actinomycetes and Rhizobiaceae. In general, the expression of glutamine 
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synthetase is regulated by nitrogen. However, it appears that bacteria that have more than 
one glutamine synthetase encoded in the genome, the GSI coded gene is expressed 
constitutively but with post-translational regulation by adenylylation and the GSII coded 
gene is regulated by nitrogen.  
In the case of Escherichia coli, the glutamine synthetase gene has three promoters, two 
upstream and one downstream of the glutamine synthetase DNA sequence. In addition, 
there are two nitrogen regulatory genes downstream of the glutamine synthetase DNA 
sequence, which also form part of the overall mechanism for regulating glutamine 
synthetase levels.  
 
Figure 1.5    Escherichia coli glnA (glutamine synthetase) DNA map showing upstream and 
downstream regulatory sequences for glnA (glutamine synthetase). The operon has three 
promoters, glnAp1, glnAp2 and glnLp, and further downstream two nitrogen regulatory 
genes. 
The three promoters shown in relation to glnA (glutamine synthetase DNA sequence) in 
Figure 1.5 enable the cell to maintain a low level glutamine synthetase (product of glnA) 
and NRI (product of ntrC) during growth with an excess of nitrogen and to increase the 
level of glutamine synthetase and NRI rapidly in response to a low level of nitrogen 
(Reitzer & Magasnik, 1987). In cells growing under carbon limitation, but with an excess 
of nitrogen, glnA is transcribed from glnApl, which is partially repressed by NRI, resulting 
in a low level of glutamine synthetase. The cells also maintain a low level of NRI, through 
transcription initiated at glnLp (Reitzer & Magasnik, 1987). 
In the case of Escherichia coli the following key genes and their associated products that 
are involved in transcriptional regulation are listed in Table 1.1. 
Gene Product 
glnA glutamine synthetase 
glnB PII 
glnD uridylyltransferase / uridylyl removing enzyme 
glnE Adenylyltransferase 
ntrB nitrogen regulator I (NRI) 
ntrC nitrogen regulator II (NRII) 
rpoN (glnF, ntrA) σ60 
Table 1.1     Escherichia coli regulatory genes and product involved for glutamine synthetase 
regulation (reproduced from Reitzer & Magasnik, 1987) 
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The regulation of the transcription of glnA in response to the availability of nitrogen is 
achieved through the action of uridylyltransferase/uridylyl-removing enzyme (PII) 
nitrogenregulator I (NRI,), and nitrogen regulator II (NRII). This requires core RNA 
polymerase and σ60. When the intracellular concentration of 2-ketoglutarate is high, 
uridylyltransferase converts PII to PII-UMP. In the absence of PII, NRI catalyses the 
conversion of NRI to NRI-phosphate, and this phosphorylated protein then activates the 
initiation of transcription at the σ60dependent promoter glnAp2. When the intracellular 
concentration of glutamine is high, uridylyl-removing enzyme converts PII-UMP to PII. 
This subsequently causes NRII to remove the phosphate group from NRI-phosphate, which 
in turn, halts the initiation of transcription from glnAp2. 
In cells growing under carbon limitation, but with an excess of nitrogen, glnA is 
transcribed from glnApl, which is partially repressed by NRI, resulting in a low level of 
glutamine synthetase (Reitzer & Magasnik, 1987). The cells also maintain a low level of 
NRI, through transcription initiated at glnLp. Cells maintained in a nitrogen-deprived 
medium result in the activation of uridylyltransferase by the increase in intracellular 2-
ketoglutarate. When cells are maintained in a nitrogen deprived medium, there is an 
increase in intracellular ketoglutarate which results in the activation of uridylyltransferase.  
The uridylyltransferase then converts PII to PII-UMP and allows NRII to convert NRI, to its 
active form, NRI-phosphate. NRI-phosphate can, in turn, fully activate the initiation of 
transcription at glnAp2 by σ60-RNA polymerase. The level of intracellular NRI is increased 
through the transcription of glnG initiated at glnAp2. The increase in the level of NRI 
results in complete repression at glnApl and glnLp. A shift of the cells from nitrogen 
starvation to nitrogen excess causes the activation of uridylyl-removing enzyme through 
the increased intracellular glutamine and the removal of UMP from PII-UMP by uridylyl-
removing enzyme. The resulting PII causes NRII to remove the phosphate from NRI,-
phosphate, thereby stopping the initiation of transcription from glnAp2. Maintaining 
growth in this medium results in decreased levels of glutamine synthetase and NRI 
dilution, which eventually leads to sufficient lifting of the repression at glnApl and glnLp, 
to allow both glutamine synthetase and NRI to be maintained at low levels (Reitzer & 
Magasnik, 1987). 
Whilst the complexities of transcriptional feedback regulatory mechanisms have been 
extensively studied in enterobacteriaceae, especially Escherichia coli, studies in some of 
the other organisms have indicated interesting differences. In the case of Bacteriodes 
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fragilis, GS activity is maintained only by transcription of glutamine synthetase which is 
regulated by nitrogen (Abratt et al., 1993). In the case of Clostridium acetobutylicum, there 
is an antisence coded glutamine synthetase sequence downstream of the glutamine 
sequence. Fierro-monti et al. (1992) found that there was reduced GS activity when 
expression of a antisense RNA was increased.  The antisense RNA expression was 
repressed in nitrogen limiting media but induced in nitrogen-rich media. Hence the level of 
antisense RNA expression, determines the translation of glutamine synthetase thereby 
regulating glutamine synthetase activity 
1.2.5 Glutamine Synthetase Structure and Phylogeny 
Structure determination through electron microscopy and crystallography for Glutamate 
synthetase was started as early as 1969. Sub-atomic depositions in PDB indicate structures 
consisting of 10 or 12 monomers arranged in a double ring structure with dihedral group 
symmetry.  
1.2.5.1 Typical Glutamine Synthetase structures  
Since the recent deposition of the crystal structure of type III glutamine synthetase from 
Bacteroides fragilis (PDB ID: 3O6X; Rooyen et al., 2011) structures off all three 
glutamine synthetase families derived by X-Ray crystallography are now represented. The 
monomer protein sequences for each of the depositions below can be found in Appendix 
D. 
GS 
Type Organism 
Monomer 
amino acid 
Sequence used 
in alignment PDB Deposition Variants 
II 
Zea mays 356 2D3A (2005) 2D3B (2005); 2D3C (2005) 
Saccharomyces cerevisiae 370 3FKY (2008) - 
Canis familiaris 381 2UU7 (2007) - 
Homo sapiens 384 2OJW (2007) 2QC8 (2007) 
I 
Salmonella typhimurium 468 1F52 (2000) 2GLS (1989); 2LGS, 1LGR (1994); 1F51, 1FPY (2000) 
Synechocystis sp 473 3NGO (2010) - 
Mycobacterium tuberculosis 486 2BVC (2005) 1HTO, 1HTQ (2001); 2WGS, 2WHI (2009); 3ZXR, 3ZXV (2011) 
III Bacteroides fragilis 729 3O6X (2010) - 
Table 1.2     PBD glutamine synthetase depositions. The different colours reflect glutamine synthetase 
type. The typical difference between type II and type 1 is 100 amino acids and a much 
larger difference between type 1 and type III of around 250 amino acids. 
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Size of the monomer easily distinguishes glutamine synthetase type as can be seen in 
Table 1.2. The typical macromolecule structure in each of the GS type and their relative 
size differences are indicated in the Figure 1.6.  
GS II GS I GS III 
Homo Sapiens Salmonella typhimurium Bacteroides fragilis 
φ115 x 90  Å φ 140 x 110 Å φ 180 x 170 Å 
  
 
 
  
Figure 1.6    Glutamate synthetase structures of type II,I and III. The double ring structure is 
characteristic of glutamine synthetase. Figure a and b reproduced from  W. Krajewski et 
al., 2008, GS II from PDB 1F52 and GS III from PDB 3O6X visualized in Chimera. 
Rooyen et al., 2011 makes an interesting observation that in the case of GS III the 
orientation of the hexameric rings is inverted in comparison to other GS families. 
1.2.5.2 Glutamine synthetase Phylogeny 
GS I has been primarily associated with Prokaryotes, and GS II with Eukaryotes but more 
recently multiple isoforms can sometimes be found in the same organism. GS III on the 
other hand, is much longer than both GS I and GS II. Pesole et al. (1995) showed that the 
divergence between the GS I and GS II forms occurred about 2500 million years ago. The 
common ancestor of the GS II genes found in plants and animals precedes the divergence 
between plants and animals. 
When considering all three GS families simultaneously, a high level of sequence similarity 
in five regions are conserved (Janssen et al., 1988), which would be helpful towards a 
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structure prediction using existing models as templates. The length between regions II and 
III is also similar across all glutamine synthetase types. The adenylylation loop sequence is 
only conserved in GS I family of enzymes. 
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The sequences of the conserved regions are indicated in the Table 1.3 using Salmonella typhimurium as the template sequence. These 
conserved regions are indicated using Clustral W (Larkin et al., 2007) pairwise alignment tool (but with the gaps removed) in Figure 1.7 to 
also show the conservation of length between region 2 and region 3 in all GS types.  
R1 50-FDGSSIGGWKGINESDMVLMPDASTAVIDPFF R3 254-TFMPKPMFGDNGSGMHCHMSL R5 357-IEVRFPDPAANPYLCFA 
R2 211-HEVATAGQNEVAT R4 337-RNRSASIRIP A1 398-IHPGEAMDKNLYDLPPEE 
Table 1.3     Conserved DNA sequences in glutamine synthetase family using Salmonella typhimurium template for sequence reference. 
 Figure 1.7    Glutamine synthetase multiple alignments of PDB depositions, centered on regions II and III. The Five conserved regions and adenylylation loop are 
indicated and shown according to the colour key: Red=Region1 – Latch; Brown=Region2 – Enzyme Active Site; Magenta=Region3 ATP binding site; 
Green=Region4 Glutamate Binding Site; Blue=Region5 Enzyme Active Site and Grey= Adenylylation Loop. The gaps have been removed in the 
alignment to indicate the length of the region between R2 and R3 is conserved in all GS types whilst GS I and GS II share a similar length between R2 
through to R5.
                                                
1 Adenylylation Loop 
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The multiple alignment scores between the GS’s are indicated in Table 1.4. 
Table 1.4   Sequence Identity between glutamine synthetases of different organisms. The sequence 
similarity between GS types is low (between 14 -24%), whereas in the same GS type the 
similarity increases to greater than 50%. GS I=Green;GS II=Yellow and GS III=Grey. 
The sequence similarity within each type (highlighted in yellow and green in Table 1.4) is 
greater than 50%.  
1.2.5.3 Glutamine Structure function 
The five regions of high sequence similarity as shown in Table 1.3 have the following 
functional importance: 
• Regions II and V – enzyme active site 
• Region I – Latch region 
• Region III – ATP binding site 
• Region IV – Glutamate binding site 
• Adenylylation loop – in GS I 
Eisenberg et al. (2000) have extensively reviewed the structure of glutamine synthetase, 
describing the active site as a bi-funnel in which the glutamate and ATP bind at opposite 
ends. The two divalent cation binding sites (referred to as n1 and n2 cation) are found at 
the joint of the bi-funnel. Three glutamate side chains bind the n1 cation and help in 
stabilizing the protein. The n2 cation is involved in phosphoryl transfer held in place by 
two glutamate ligands and a histadine side chain. Pesole and Lanave (1991) showed that 
the cation ligands are highly conserved in glutamine synthetase.  
Both the N-terminus and C-terminus of each monomer are helical. The two rings of the GS 
macromolecule are held together mainly by hydrophobic and hydrogen bonding 
interactions (Almassy et al., 1986). In general, the N-terminus helix sits above the ring 
GS 
TYPE 
Deposition & 
Chain Length 
Organism 
II I 
2D3A 3FKY 2UU7 2OJW 1F52 3NG0 2VBC 
II 
2D3A 356 Zea mays        
3FKY 370 Saccharomyces cerevisiae 57       
2UU7 381 Canis familiaris 54 53      
2OJW 384 Homo sapiens 54 54 96     
I 
1F52 468 Salmonella typhimurium 21 23 23 24    
3NG0 473 Synechocystis sp 22 24 21 22 57   
2VBC 486 Mycobacterium tuberculosis 22 21 19 20 56 52  
III 3O6X 729 Bacteroides fragilis 16 15 14 14 19 17 16 
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exposed to solvent, whilst the C-terminal helix is inserted into a hydrophobic hole in the 
subunit of the opposite ring.  
The adenylylation loop containing a tyrosine residue is covalently modified by the addition 
of AMP. This loop sits just outside the bottom entrance of the bi-funnel. 
The functional study of Mycobacterium tuberculosis glutamine synthetase by Eisenberg et 
al. (2000) postulates the workings of the latch region as follows:  
1. Residues 323-330 form a loop that guards the glutamate entrance to the active site. 
2. The loop closes the active site, shielding the γ-glutamyl phosphate intermediate 
from aberrant hydrolysis. 
3. Glu-327 carboxylate forms a part of the ammonium site. 
4. When the loop closes the glutamate entrance to the active site, Asp-50 deprotanates 
the ammonium ion, forming ammonia, which in turn attacks the γ-glutamyl 
phosphate intermediate thereby forming a tetrahedral intermediate, yielding 
glutamine.  
5. The loop in the closed position is thought to increase the inter-subunit stabilization 
through interaction with Ser-52P or Ser-53P of the adjacent subunit. 
Krajewski (2008) has crystallized Mycobacterium tuberculosis glutamine synthetase with 
different analogues in the binding sites. Some of the inhibitors identified from high 
throughout screening and subsequently optimized on Mycobacterium tuberculosis 
glutamine synthetase (glnA1) were carried out on whole cell Mycobacterium tuberculosis  
(Couturier et al., 2015). None of the inhibitors was found to be active on the whole cell M. 
tuberculosis. Couturier et al. (2015) concluded that Mycobacterium tuberculosis glutamine 
synthetase (glnA1) is not a suitable anti-tubercular drug target. Further structural studies on 
Mycobacterium tuberculosis glutamine synthetase remains an ongoing research area. 
1.3 Aims	  of	  this	  Study	  	  
Enabling the design of new drugs that will inhibit Plasmodium falciparum glutamine 
synthetase will require its structure. At present the structural knowledge of PfGS is limited 
to its sequence. In this study we hope to gain further structural and other information that 
will contribute ultimately to the atomic resolution study that will be necessary for the 
interpretation of drug binding data. 
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The specific aims of this project were to: 
a) Clone and produce soluble and active Plasmodium falciparum glutamine 
synthetase.  
b) Purify the Plasmodium falciparum glutamine synthetase to homogeneity 
c) To determine the 3-D structure of PfGS by negative stain single particle electron 
microscopy. 
d) Use homology modelling to generate a model for PfGS to interpret the EM density. 
 
The known Plasmodium falciparum genome sequence facilitated the synthesis of the gene 
encoding glutamine synthetase protein that was the starting point for this study. The work 
presented here demonstrates the expression and purification of a soluble, intact, active 
enzyme. This enzyme was further characterized with respect to its thermostability as a 
prelude to crystallization trials. Structural data in the form of negative stain electron 
micrographs were obtained and these enabled a three-dimensional reconstruction that 
demonstrated that the enzyme was a dodecamer. 
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Chapter	  2	  −	 Expression	  and	  purification	  of	  recombinant	  
Plasmodium	  falciparum	  Glutamine	  Synthetase	  
2   
This chapter describes the initial insoluble expression and the soluble expression of 
recombinant Plasmodium falciparum glutamine synthetase from a synthetically made 
DNA sequence. Soluble expression was followed by purification of Plasmodium 
falciparum glutamine synthetase protein. 
2.1 Introduction	  
Glutamine synthetase sequence, which was found to be conserved (Berman et al., 2000), in 
the Plasmodium falciparum genome (PLASMODB gene id: PF3D7_0922600) was used 
for synthetising the DNA sequence.  
There were multiple unsuccessful attempts made to express soluble PfGS using the 
expression plasmid pETM-11_D216 prepared by GeneArt2. Subsequent analysis identified 
a further key error in the deposited sequence of this enzyme in PLASMODB (Bahl et al., 
2003). Following the alignment of the sequence of GS I from Salmonella typhimurium, it 
was noticed that the α-helix central to the inter-ring interface, was not conserved. The 
significance of this difference became clear once the important structural role of this 
element was understood. On re-examination of the sequence, the presence of an intron was 
missed which resulted in the reading of a stop codon at residue 511, which would have also 
have caused a 17 amino acid shorter protein compared to the native length. At the same 
time this discrepancy was identified, the PLASMODB website also reflected the corrected 
PfGS sequence.  
2.2 Materials	  and	  Methods	  	  
Growth media, stock solutions and buffer compositions are all detailed in Appendix A. 
2.2.1 PfGS DNA Sequence 
2.2.1.1 Codon optimization of DNA sequence 
Different organisms show marked differences in codon preferences for their gene coding. 
The Plasmodium falciparum genome is a very AT rich sequence (~80%) and is known to 
be a challenge for recombinant soluble over expression in Escherichia coli. The host codon 
                                                
2 A biological venture for commercial gain in the USA. 
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preferences and tRNA abundance relative to the requirements for the heterologous gene 
may vary vastly with the host, which could result in either slowing down or absence of 
over expression. (Bonekamp & Jensen, 1988; Robinson et al., 1984). 
Expression in Escherichia coli for the recombinant protein was preferred due to the 
availability and low cost of the expression system. The Plasmodium falciparum glutamate 
synthetase sequence was codon optimized by GeneArt for expression trials taking into 
account codon preferences (Ikemura, 1981), where possible, for Escherichia coli as the 
host strain. The native and codon optimized sequences, together with the translated protein 
sequence are included in Appendix B. 
2.2.1.2 Plasmids used for synthesized gene from Gene Art 
GeneArt (USA) synthetized the codon optimized PfGS gene and delivered it in two 
plasmid constructs, a cloning plasmid pMA with 4018 base pairs (Figure 2.1) and an 
expression plasmid pETM-11_D216 with 7005 base pairs (Figure 2.2).  
 
Figure 2.1    Map of pMA Cloning plasmid used for insertion of synthesised gene. pMA is ampicillin 
resistant. (Reproduced from GeneART documentation) 
 19 
 
Figure 2.2    Map of pETMM1_D216 expression plasmid used for the insertion of synthesised gene.  
pETM-11_D216 is kanamycin resistant. (Reproduced from GeneART documentation) 
Five micrograms of each plasmid construct was received and re-suspended in 50 µl TE 
buffer (2.2.9 Appendix A). The pMA (GeneArt) plasmid is ampicillin resistant whilst the 
pETM11-D216 (GeneArt) is kanamycin resistant. 
2.2.1.3 pCold I Plasmid 
Reducing the incubation temperature sufficiently induces a group of “cold shock” proteins 
in Escherichia coli to be expressed. The pCold I (Takara) plasmid (Figure 2.3) utilizes one 
of the cold shock genes as a promoter for inducing over-expression. Takara markets four 
kinds of pCold plasmids, whose arrangements vary in the existence of translation 
enhancing element (TEE), hexa-histidine tag sequence and Factor Xa cleavage site.  
 
Figure 2.3    pCold I plasmid map used for the cold shock over-expression. pCold I is ampicillin 
resistant. (reproduced from GeneART documentation) 
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The pCold I vector shown in Figure 2.3 was selected for expression trials, with the view of 
using the N-terminal hexa-histidine tag towards a single step purification process. The 
pCold I vector is optimized for expression at 15°C. 
2.2.2 Transformation of Competent Cells 
Competent cells that had been stored at -20°C were thawed on ice for 10 minutes. Plasmid 
DNA was (aim for 1-50 ng) added to 100 µl of competent cells. Incubated on ice for 
20 minutes. Heat shock cells at 42°C for 5 minutes and quenched of ice for 2 minutes 
before adding 900 µl of culture media (LB). Incubated at 37°C or 60 minutes.  Spread 
100 µl cell onto LA plate with antibiotic selection. Incubated petri dish at 37°C overnight 
then stored plate at 4°C. 
Competent cells of Escherichia coli strains BL21(DE3), BL21(DE3) pLysS, BL21(DE3) 
C41, and BL21(DE3) Rosetta Gami were used in the transformations. Three plasmids were 
used in the transformations, namely pMA (GeneArt), pETM11_D216 (GeneArt) and 
pCold I (Takara). Plasmids pMA and pCold I are ampicillin resistant and pETM-11_D216 
is kanamycin resistant.   
2.2.3 Expression Protocols 
2.2.3.1 Standard expression protocol 
A single colony was inoculated in 10 ml LB growth media with antibiotic selection and 
incubated at 37°C for 16 hrs to produce a starter culture. Expression trials were conducted 
in either 250 ml or 1000 ml growth media preparations with antibiotic selection inoculated 
with starter culture 1:500. Cell growth was monitored by measurement of absorbance at 
600 nm. Expression was induced with 0.2 mM IPTG when absorbance at 600 nM reached 
0.5. Incubation was continued for a further 16 hours. Cells were collected by centrifuging 
media at 4500 rpm and discarding the supernatant. At this stage, the cells were stored 
at -18°C.  
Cells were re-suspended in a precooled (4°C) phosphate buffer at 20 mM pH7.5. Cell lysis 
was achieved by 15 seconds intermittent sonication for 4 minutes on ice using a microtip 
operating at a power output of 65W (Misonix Sonicator). The whole cell extract was 
centrifuged at 4°C for 20 minutes at 20000 x g and the cell free extract was collected.  
2.2.3.2 Cold Shock Expression 
The cold shock expression is similar to the standard expression protocol except for:  
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a) Induction takes place after growth culture was cooled for 30 minutes at 15°C.  
b) Induction with IPTG at a final concentration of 0.4 mM in growth media. 
c) Post induction incubation was for 24 hours at 15°C. 
 
2.2.4 Standard Protein Protocols 
2.2.4.1 SDS-PAGE  
Visualisation of protein size was carried out according to Laemmli using a Mini-
PROTEAN 3 cell from Bio-Rad with 10% separating gels. Pre-stained molecular markers 
(Fermentas Life Sciences) were included in the SDS-PAGE electrophoretic separations.  
Gel separating solution was pipetted into an assembled glass slide and overlaid with 2 ml 
isopropanol. Polymerization was allowed to take place for 30 minutes. Removal of the 
overlay and pipette prepared stacking gel solution on top of the polymerized separating gel 
was followed immediately by inserting the gel comb, ensuring a neat fit and without 
trapping any bubbles. We allowed polymerization of stacking gel for 30 minutes and 
removed the comb carefully. 
We assembled the glass slide into the running tank according to the manufacturers 
instruction and filled the tank with running buffer. Steps followed were: 
Prepared 20 µl of sample volumes in fresh eppendorfs (16 µl sample/dH2O with 4 µl 
5 x sample buffer) and denatured protein for 5 minutes in boiling water before loading. 
Samples were loaded in respective lanes and order of loading was noted. 
Ran the gel at room temperature at a constant 30 mA until detection of the blue front was 
within 5 mm of the slide edge. Disassembled the gel slide plates and carefully freed the gel 
and put into staining solution, ensuring gel was submerged for one hour with gentle 
agitation. The submerged gel was placed into destain solution for 12 hours with gentle 
mixing and then we stored the destained gel in 7% acetic acid solution until visualized in 
light box and findings recorded.  
2.2.4.2 Bradford Protein quantification 
Freshly prepared Protein Dye Reagent (Bio-Rad) was diluted 1:5 in dH2O before use. The 
Bradford microtitre plate procedure was used. 10 µl of protein sample in triplicate was 
loaded in the microtitre 96 well plate followed by 200 µl of diluted Protein Dye Reagent. 
Absorbance was read at 595 nm in a Multiskan spectrophotometer (Titertek, Helsinki) after 
5 minutes.  
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A standard curve was prepared by replacing the sample with a known dilution series 
between 0.5 and 0 mg/ml that was made from 1 mg/ml of BSA stock. The 0 mg/ml (origin) 
was represented by a sample buffer. Plotting the absorbance against the BSA dilution 
series allowed the concentration of the sample to be computed.  
2.2.5 Standard DNA Protocols 
2.2.5.1 Agarose Gel electrophoresis 
The DNA fragments resulting from the PCR amplification were visualized by using the 
standard 1% Agarose Gel electrophoresis technique in TAE (Sigma-Aldrich) buffer and 
using EtBr as the intercalating dye. 
Samples for loading were prepared in a fresh eppendorf, by adding 2 µl DNA gel loading 
dye (Fementas), 2 µl of amplified DNA and 8 µl water. Together with the sample, a 
calibrated DNA ladder (Fementas) was also loaded in a separate lane.  
The electrophoresis was carried out at 120V until visible dye line was approximately 
75-80% of the way, down the gel. DNA bands were visualized under UV light and 
interpret bands using the calibrated DNA ladder as the reference. 
2.2.5.2 Restriction Digests 
All restriction enzymes and the respective buffers were obtained from NEB (New England 
BioLab). In a clean eppendorf we prepared a 20 µl double digest reaction mixture, by the 
addition of 1 µg DNA, 1 unit enzyme A, 1 unit enzyme B, 2 µl of the recommended buffer 
made up with dH2O. The reaction mixture was all settled in the bottom of eppendorf by 
centrifuging briefly. The reaction was allowed to incubate for 1 hour at 37°C then heat 
inactivated at 65°C for 20 minutes. Cooling was carried out on ice for 10 minutes before 
storing at 4°C. 
2.2.5.3 Plasmid Dephosphorylation  
Dephosporylation of the digested plasmid was done using the calf intestine alkaline 
phosphatase. The manufacturers digest protocol was followed, whereby 3 µl 
de-phosphorylation buffer, 3 µl calf intestine alkaline phosphatase (Sigma-Aldrich) and 
4 µl dH2O was added to the completed plasmid digest, incubated for 30 minutes at 37°C 
and heat inactivated at 65°C for 20 minutes. The dephosphorylated plasmid was stored at 
4°C. 
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2.2.5.4 Ligation Protocol  
The ligation protocol assumed the plasmid was dephosphorylated. We added in a clean 
Eppendorf 25 ng DNA insert fragment, 100 ng dephosphorylated plasmid DNA, 2 µl 
ligation buffer (Fermentas), 1 unit of T4 DNA ligase (Fementas) and made up reaction 
volume to 20 µl using dH2O. Reaction was allowed to incubate for 16 hours at 16°C and 
then heat inactivated at 65°C for 10 minutes. Cooling was carried out on ice for 10 minutes 
before storing at 4°C. 
2.2.5.5 PCR Amplification 
Amplification was done using Phusion® Hot Start high fidelity DNA polymerase kit (New 
England BioLabs). Reaction mixtures of 50 µl were prepared as recommended for the use 
of the polymerase kit. 
Step Temperature Duration 
Initial Denaturation 98 °C 30 seconds 
25 cycles - Denaturation 
- Annealing 
- Extension 
98 °C 
Primer Tm + 3 °C 
72 °C 
10 seconds 
30 seconds 
15-30 seconds / kb of DNA 
Final Extension 
tension 
72 °C 10 minutes 
Hold 4 °C  
Table 2.1     PCR thermo cycling conditions recommended by the manufacturer. The lower of the two 
primers melt temperature was used and extension time rounded to the nearest 30 seconds 
using the lower end of the extension per kb. 
The manufacturer set out recommended conditions for the thermo cycling is indicated in 
Table 2.1, which was used for the amplification.  
2.2.6 DNA Primer Designs  
2.2.6.1 For Amplification of PfGS from vector pMA (GeneArt) 
Insertion of PfGS was chosen to be between Nde I and Kpn I in the multiple cloning site of 
the pCold I vector to ensure correct orientation and maximizing utilisation of existing 
restriction sites at the multiple cloning site as shown in Figure 2.4. 
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Figure 2.4    pCold I Multiple Cloning Site shown from 5’ to 3’. Recommended forward and reverse 
amplification primers are shown.  
Ensuring correct orientation during insertion and DNA reading frame alignment for PfGS 
sequence required the introduction of a Nde I restriction site during PCR amplification. 
 
Figure 2.5    Primer design for amplification of PfGS in pMA. DNA sequence in the vicinity of the 
N-terminus and C-terminus of PfGS insertion region is indicated. To enable a Nde I 
restriction site to form a 3 codon, CAT insertion is required instead of TTC for the 
forward primer. 
As there was no Nde I restriction site available in the pMA plasmid, (Figure 2.1), a site-
directed mutagenesis of three codons (CAT) was introduced, as can be seen in Figure 2.5, 
to ensure a Ndel I site results during gene amplification. The Kpn I site already existed in 
both the pMA construct at the C-terminal end and at the pCold I multiple cloning site.  
Primer Sequence Length (bp) Tm (°C) 
Forward 5’ CATGGAACATATGAAGAGCGTTAGC 25 56.0 
Reverse 5’ GAGGTACCCTCGAGTTAGCATTCG 24 59.1 
Table 2.2     Primers to amplify PfGS from pMA vector (GeneArt).  
The forward and reverse primers as indicated in Table 2.2 were synthesized by Integrated 
DNA Technologies and diluted to 100 µM stock.  
2.2.6.2 For Amplification of PfGS from vector pCold I (Takara) 
Primers as recommended by Takara as shown in Figure 2.4 for the verification of the insert 
DNA sequence in pCold I were used. 
Primer Sequence Length (bp) 
Forward 5’ ACGCCATATCGCCGAAAGG   19 
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Reverse 5’ GGCAGGGATCTTAGATTCTG 20 
Table 2.3     Primers to amplify PfGS in pCold I vector (Takara).  
The forward and reverse primers as indicated in Table 2.3 were synthesized by Integrated 
DNA Technologies and diluted to 100 µM stock.  
2.2.7 DNA Purification  
2.2.7.1 DNA from PCR amplification 
In preparation for efficient restriction enzyme digest, the amplified DNA was purified 
using a proprietary NucleoSpin® Extract II kit. Essentially the DNA is bound to a silica 
membrane and contaminants removed by a few washing steps. The pure DNA is then 
eluted with a slightly alkaline buffer (Tris/HCl, pH 8.5). Dilution of the binding buffer 
determines the size of the DNA fragments that will bind. To exclude binding of less than 
1000 bp of DNA, the binding buffer provided in the kit was diluted 1:5 with water. 
2.2.7.2 DNA purification after Restriction Digest 
The digested DNA was loaded on 1% Agarose gel and after the electrophoresis run, the 
required DNA bands were excised and placed into clean Eppendorf tubes. The excised 
agarose gel with DNA fragment was dissolved and DNA fragment extracted in accordance 
with the proprietary NucleoSpin® Extract II kit recommendations. 
2.2.8 Protein Purification 
Purification was achieved by immobilized metal affinity chromatography and competitive 
binding of imidazole eluted PfGS.  
2.2.8.1 Cell Lysis  
The standard protocol for lysis by sonication was used. 
Cells were re-suspended with 3 ml pre-cooled buffer3 at 4°C per gram of cell weight. 
Power output was set at 65 W and sonication for 4 minutes with 15 seconds intermittent 
cycles (Misonix Sonicator) using a microtip. Cell free extract was collected following 
centrifuge at 4°C for 20 minutes at 20 000 x g. 
It was important that the subsequent purification after cell lysis is done in quick succession 
and as far as possible below room temperature.  
                                                
3 Re-suspension buffer used was 20 mM Na2HPO4 buffered to pH7.5 with NaH2PO4 + 50 mM Imidazole + 
0.1 mM MnCl2.  
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2.2.8.2 Affinity Chromatography 
A 5 ml His-trap Fast Flow™ (GE Healthcare) Ni-affinity column was loaded with filtered 
cell free extract after filtering with a 0.45 µm filter at 1 ml/min in a 4°C chamber. Two 
column washes (10 ml) were effected with pre-cooled wash buffer (50 mM imidazole). 
The loaded and washed affinity column was placed in a modular Gilson system, with 
Gilson 321 pump, Waters detector and Gilson fraction collector. Protein was eluted using a 
linear gradient of elution buffer (500 mM imidazole at a flow rate of 2.5 ml/min over 25 
minutes. Fraction collector was set to collect in intervals of 1 minute. 
Consolidation of the fractions was based on collecting the fractions around the peak 
absorbance tube and presence of GS activity using the Υ-glutamyl transferase (GGT) 
assay. 
The protein was exposed to room temperature only during the fractionation step. This 
exposure was further minimised by ensuring the buffers are pre-chilled and kept on ice 
during the entire fractionation and each fraction collection tube on completion was 
transferred immediately to ice. 
GS activity was assayed by the  γ-glutamyl transferase (GGT) assay as described by 
Bender et al., (1977). Assay volumes were reduced to allow measurements in the Titertek 
Multiscan plate reader. In a clean eppendorf 66.7 µl of reaction mix, 8.33 µl of Glutamate 
(0.2mM) and 8.33 µl of sample were added. A blank reaction eppendorf is also included 
(i.e. sample replaced with dH2O). The solution was incubated at 37°C and the stop reaction 
solution added after 5 minutes. The stopped reaction was then centrifuged at 5000 rpm for 
5 minutes to remove any precipitants. The supernatant was loaded in the microtiter plate 
and absorbance at a wavelength of 540 nm recorded. The reaction product is glutamyl 
hydroxamate. One unit of GS activity is defined as production of 1 µmol of glutamyl 
hydroxamate per minute. 1 µmol of glutamyl hydroxamate is represented by 2.916 of 
absorbance units at wavelength of 540 nm. 
2.2.9 Buffer Exchange and Protein Concentration 
The Amicon® stirred cells device with a 100 kDa filter was used. The device used has a 
capacity of 50 ml. 
The starting solution was diluted 1:1 with the final buffer and concentrated in the 
Amicon® stirred cell device to ~5 ml. The Amicom device was refilled until all diluted 
solution was loaded. The cycle of concentrating to 5 ml and reloading with the final buffer 
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was repeated for two cycles. The final preparation was concentrated to around 2 mg/ml and 
flash frozen in Cryo Tubes under liquid nitrogen for storage.  
For concentrations greater than 2 mg/ml the addition of 10% glycerol and 0.4 mM beta-
octyl glucoside was made to the buffer. 
2.2.10 Differential Scanning Fluorimetry 
Differential scanning fluorimetry (DSF), using a SYPRO orange probe (Niesen et al., 
2007), was used to rank the thermal stability of PfGS. DSF essentially monitors the 
unfolding of the protein in the presence of a fluoro probe, using a real time PCR 
instrument.  
The ROTO-GENE 6000 PCR machine, having the necessary excitation and emission 
wavelengths but without refrigeration attachment, was available. The experiment started at 
25°C. Each reaction volume was 40 µl, with 0.003 mg of PfGS with recommended dilution 
of SYPRO orange and buffer conditions being tested. 
2.2.11 Protein Sequencing 
The synthesized primers, together with the isolated plasmid DNA, were sent to Macrogen 
(South Korea) laboratories for analysis by using the standard Sanger sequencing.  
2.2.12 Mass Spectrometry  
Sequencing of purified protein was done using MALDI-TOF and by BLAST using the 
trypsin digest peptide mass fingerprint. The services were outsourced to the Molecular and 
Cell Biology department at the University of Cape Town. 
2.3 Results	  
2.3.1 Visualisation of Soluble Expression with pETM-11_D216 in Escherichia coli  
Transformations into the four strains4 of Escherichia coli were successful, as indicated by 
growth of anti-biotic (kanamycin) resistant colonies on LA-plates. 
                                                
4 BL21(DE3), BL21(DE3) pLysS, BL21(DE3) Rosetta-gami and BL21(DE3) Overexpress C41 
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Figure 2.6    SDS-PAGE visualisation using Gel Doc XR™ imager of soluble expression in 
Escherichia coli . The lane headers 6 is strain BL21 (DE3), 9 is strain BL21 (DE3) pLysS 
and 4 is the ladder.  No visual bands could be seen at the 63 Kda band, however the Gel 
Doc at low sensitivity emphasizes a potential band at this region (red line) in the case of  
BL21 (DE3) pLysS. 
 
Figure 2.7    SDS-PAGE visualisation using Gel Doc XR™ imager of soluble expression in 
Escherichia coli . The lane headers 4 is strain BL21 (DE3) RossetaGami, 8 is strain BL21 
(DE3) Overexpress C41 and 9 is the ladder.  No visual bands could be seen at the 63 Kda 
band, however the Gel Doc at low sensitivity emphasizes a potential band at this region 
(red line) for both strains. 
Over-expression in the 63 kDa (PfGS) band was expected. No band was visible in the 
expected range when viewed under the light box. The gel was then also analyzed using the 
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Gel Doc XR™ (Bio-Rad) imager and Quantity One Version 4.5.2 software, with the 
sensitivity set to low to allow low levels of detection. Three of the strains indicated a 
possible band around 63 kDa as indicated in Figure 2.6 and Figure 2.7 by the red lines 
drawn by the software in attempting to indicate an identified band.   
Ni-affinity purification was then carried out on the cell free extract of Escherichia coli 
BL21 (DE3) expression which indicated no absorbance peaks beyond 30% of the elution 
buffer (150 mM imadazole) and no GS activity as measured by the GGT assay in any of 
the elution tubes. It was therefore concluded that no soluble expression of PfGS was 
achieved. 
2.3.2 Confirmation of DNA Sequence of the Insertion in pCold I  
The returned sequence chromatograms from Macrogen were analyzed using software 
version 2.01 of Chromas (Goodstadt & Ponting, 2001) and the DNS sequence was  
confirmed to align with the codon optimized gene sequence, received from GeneArt for 
PfGS. 
2.3.3 Size of Amplified DNA Fragment from pCold I (PfGS) construct 
The expected fragment size of the amplified DNA fragment including the overhangs of 
both the primers was 1661 base pairs.  
 
Figure 2.8    Agarose Gel of PCR amplified product in first five lanes and the DNA ladder in the last 
lane. The amplified product band is indicated at the band size of  ±1.7 kbp. 
The bands from the agarose gel electrophoresis run as shown in Figure 2.8 confirms 
amplified DNA sequence at the expected size of 1.7 kbp. 
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2.3.4 Affinity Chromatography Fractionation Profile 
A summary of the fractionation elution profile indicates a peak elution after 18.5 minutes. 
 
Figure 2.9    Absorbance profile of elution with linear gradient of elution buffer. Absorbance units at 
280 nm indicated on right hand scale. Elution peak at 350 mM imidazole (in tube 19). A 
second characteristic peak towards 500 mM imidazole in tube 25. 
Figure 2.9 indicates that elution towards the first first peak starts at ±45 % of buffer B (± 
225 mM imidazole concentration) and peaks at ±75 % of buffer B (± 375 mM imidazole 
concentration). 
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 Figure 2.10  Protein concentration (µg/ml) vs GS activity (absorbance units) for the collected fractions 
in each of tubes 12 -28. The original elution absorbance at 280 nm (x10) is superimposed 
for comparative purposes.  The Protein concentration and GS assay were not done in 
triplicate. Tubes 16 to 22 were consolidated as purified protein. 
Figure 2.10 indicates that protein concentration measured in the fractionated tubes is in 
line with the elution profile of absorbance at 280 nm.  
 
Table 2.4     GS activity and specific activity in fraction tubes 12 -28. Both Protein and GS assay were 
not done in triplicate as no purification table was being attempted. 
Table 2.4 indicates activity in Units (µmol of glutamyl hydroxamate per minute) The 
average specific activity over all the tubes (12-28) averages 3485 U/mg with an 8% (269 
U/mg) standard deviation. Samples were not tested in triplicate as the measure was meant 
to provide a qualitative indication of activity. The total eluted protein between tubes 12 to 
28 and the consolidated tubes 16-22 were estimated to be 2.6 mg and 1.5 mg respectively. 
2.3.4.1 Verification of and purity of fractionated PfGS 
Third party mass spectrometer (Maldi-TOF) of the purified PfGS, confirmed using the 
peptide mass fingerprint from a trypsin digest that the sequence represented “Glutamine 
synthetase, putative Plasmodium falciparum (3D7)” with a p-value = 0.00012 (<0.05 
implies very significant). 
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 Figure 2.11  SDS –PAGE visualisation of purified PfGS from the peak fraction (tube 19) and the 
consolidated fractions of tubes 16-22. Under lightbox conditions only a single band was 
visible at  ±63 kDa. 
SDS-PAGE gel in Figure 2.11 of both the peak fraction (tube 19) and the consolidate 
sample (tubes 16-22) indicates a single band, indicative of high purity fractionation.  
2.3.5 Thermal Stability 
The ligands involved in the reaction of GS were used to check impact on the thermal 
 stability.  The cases considered were Glutamate/ATP (forward reaction), glutamine/ADP 
(reverse reaction) and methionine sulfoxide (a known inhibitor). Melt curves for four cases 
each with either Mn++ or Mg++ as cation were undertaken in the phosphate buffer. Cation 
and Ligands were introduced at 0.1 mM in the final concentration.  
Ligands Designation Mn++ Mg++ Delta Tm 
None Initial With no cation < 25 
None Cation 35 27 8 
ATP+GLU Reverse 35.9 27.8 8.1 
ADP+GLN Forward 35.9 31.4 4.5 
MetSox Inhibitor 36.2 33.4 2.8 
Table 2.5     PfGS melt temperatures (Tm) using DSF with different ligands. The ROTOGENE PCR 
machine was unable to record below 25°C. The Mn++ cation provides a higher thermal stability than 
the Mg++ Cation. The impact on improved stability due to the addition of ligands to either cation is 
marginal. 
With no cation present in PfGS, unfolding at 25°C was already indicated on the PCR 
machine. The results of the DSF experiment in Table 2.5 demonstrated that the enzyme 
(PfGS) was stabilized by the presence of either Mn++ or the Mg++ cation. The Mn++ cation 
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provided a higher thermal stability. The ligands did not increase the thermal stability 
significantly.  
2.4 Discussion	  
The initial trials resulted in no soluble expression as indicated by SDS-PAGE. Using the 
Ni-affinity chromatography to purify the expression products from the BL21 (DE3) strain 
indicated no visible elution peaks between 150 mM imadizole to final elution buffer 
concentration of 500 mM imidazole. No GS activity was found in any of the same 
fractions.  
Other expression trials with the pETM11_D216 at lower incubation temperature post 
induction to 20°C, addition of magnesium (to final concentration of 5 mM) to the culture 
medium, were undertaken on all four Escherichia coli strains. The lower temperature was 
introduced in an attempt to reduce metabolic strain; whilst the cation was introduced to 
ensure two cations per subunit of glutamine synthetase was available for structural 
stability.  None of the expressions trials resulted in any visible soluble expression being 
visible on the SDS-Page gel viewed under the light box. 
A different approach to using the traditional Escherichia coli expression protocols was 
necessary. Splicing of a known folding gene upstream (also known as a chaperone gene) 
was considered, but given the already large DNA sequence length of Glutamate 
Synthetase, this approach was not selected. 
As the formation of the macromolecule of PfGS was likely to consist of a oligomer of 8, 
10 or 12 monomers, splitting the sequence into smaller domains was considered to be 
unfavourable towards the formation of the macromolecule and hence eliminated as an 
option. 
The favoured approach was to reduce the metabolic expression during the growth phase of 
the strain, thereby maximizing resources for over-expression and folding of PfGS. The 
pCold vector from Takara was designed to achieve these objectives. 
Placement of the hexa-histidine tag was included in the N-terminus, informed by other GS 
sub atomic resolutions.  
The standard Sanger sequencing confirmed the inserted DNA sequence as the codon 
optimized sequence of PfGS. Mass spectrometry of the purified protein indicated with a 
high degree of confidence of the sequence being PfGS. Both the peak and consolidated 
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fractions indicated a single visible band on SDS-PAGE gel, indicating that a high level of 
purification was achieved.  
PfGS was found to precipitate when concentrating PfGS following purification. Krajewski  
(2008) also found that the introduction of cations in their buffer for the Mycobacterium 
tuberculosis GS stabilised the protein. The forward and reverse ligands only marginally 
increased thermal stability and were therefore considered optional in the buffer.   
Attempting to concentrate PfGS beyond 2mg/ml resulted in significant loss of protein due 
to precipitation. Solubility was enhanced by the addition of 10% glycerol and beta-octyl 
glucoside (at a 0.4mM final concentration) and protein concentrations as high as 8 mg/ml 
could be achieved.  
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Chapter	  3	  –	 Negative	  Stain	  3-­‐D	  Reconstruction	  	  
3  
After failing to obtain PfGS crystals using standard Hampton crystal trial screens, HR-110 
and HR-112, it was decided to pursue single particle 3-D reconstruction using negative 
stain electron microscopy of the purified PfGS towards further characterization.   
Recent advances in electron microscopy have brought cryo-electron microscopy alongside 
X-ray crystallography and NMR for structure determination and functional interpretation. 
The structure of β-galactosidase at a resolution of 3.2 Å was recently obtained by cryo-
electron microscopy (Bartesaghi et al., 2014) . This has provided the impetus for increased 
use of direct electron detectors as well as automation leading to the collection of large 
image data sets that can be processed to yield 3-D reconstructions. 
Negative stain electron microscopy is an essential prerequisite for such a high resolution 
study. Three-dimensional reconstruction of the negatively stained protein can be used, not 
only to provide a starting model for further refinement using other techniques, but also as a 
basis for homology modelling using templates from known structures.  
3.1 Single	  Particle	  Reconstruction	  and	  Resolution	  
Single particle reconstruction involves the following major steps: 
1. Specimen Preparation 
2. Image Acquisition 
3. Particle Selection 
4. 2-D Image Alignment and Clustering 
5. Starting Model Generation 
6. Back Projection and Refinement 
Steps 2 to 6 require large data handling and computational ability. Recent advances in 
computer and imaging devices have significantly impacted on electron microscopy 
reconstruction. Automated 3-D reconstruction algorithms (detailed below) are now readily 
available with user graphical interface options with a goal towards unbiased 3-D 
reconstruction.  
Two of the earliest electron microscopy software packages SPIDER (Frank et al., 1996) 
and IMAGIC (Heel et al., 1996) are still widely used. EMAN (Guang Tang et al., 2007) 
has gained usage, as the software provides some advances in overcoming model bias and 
also provides a helpful graphical interface. Other standalone software platforms widely 
used are SPARX (Hohn et al., 2007), FREALIGN (Grigorieff, 2007), XMIPP (de la Rosa-
Trevín et al., 2013) and RELION (Scheres, 2012).  A web-based development, APPION 
 36 
(Lander et al., 2009), allows a complete workflow from the control of microscope image 
through to the solving of the 3-D reconstruction. This workflow development also allows 
the use of functions from various software platforms mentioned above with appropriate 
graphical interfacing moving the bottleneck for reconstruction towards image acquisition.  
The key to producing a 3-D reconstruction is to determine the angular relationships 
between the different images captured downstream of the high-energy electrons passing 
through the macromolecule. This is achieved by taking multiple images of the same 
particle or single image of the particle in different orientations.  
Obtaining projections of the same particles as depicted in Figure 3.1(A) with 
pre-determined angular relationships is also known as a single axis tilt series. The 
pre-determined angular relationships are then used in the reconstruction protocol as 
depicted in Figure 3.1(B).  
     Figure 3.1    Visualizing single axis tilt protocol. (A) Single particle images are taken at pre-
determined angles leading to multiple views of the same particle. (B) Reconstruction of 
the single particle using the pre-determined angular views in the back projection 
(reproduced from Koster et al., 1997) 
Multiple exposures can lead to rapid degradation of a biological macromolecule and 
this method of image capture for reconstruction was excluded. 
Using randomly orientated particles, also known as single particle reconstruction, is 
depicted below. This consists of grouping and aligning the extracted particle images 
from multiple micrographs into a limited number of classes and then generating a 
back-projected 3-D model.  
 37 
 Figure 3.2    Visualizing the basics of classification and alignment of selected particles. (a) Particle selection from the micrographs. (b) Extracting of selected particles from 
micrograph. (c) Classifying selected particles into pre-determined number of classes.      
(d) Aligning and averaging particles within each class for improving signal to noise ratio. 
(reproduced from lecture notes: http://people.cryst.bbk.ac.uk/~ubcg16z/cpn/uclEM2.pdf ) 
The steps undertaken to classify and align particles is indicated in Figure 3.2. In all 
reconstruction techniques, the averaging of similar orientated particles are undertaken to 
reduce the overall signal to noise ratio that is inherent in individual images.  
 
Figure 3.3    Translational and angular parameter convention  in  orientating the different particles 
against a reference point. (reproduced from lecture notes: 
http://people.cryst.bbk.ac.uk/~ubcg16z/cpn/uclEM2.pdf ) 
Assignment of five spatial parameters, categorized into two transitional and three angular 
parameters orientate each particle relative to each other. The relative orientations are 
initially not known, as can be seen from the random orientations on the cryo-EM grid in 
Figure 3.3, but nevertheless remain essential to orientate the particle. However, various 
strategies for an initial assignment are available. Following initial assignments, they are 
reassigned in an iterative process called refinement. One such technique assumes  
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“a starting / assumed” 3-D model which is used to assign an initial orientation based on the 
best fit of the macromolecule image to give a projection of the starting model.  
The typical workflow, as indicated in Figure 3.4, uses a starting model to project 2-D 
images at pre-determined angles of the 3-D model. The 2-D raw images are then aligned to 
the projected 2-D image (also known as reference image). The angular orientations of the 
reference image that best fit the raw image is assigned to that particular raw image. It is the 
raw images and the assigned angular orientations that are used to regenerate a new 3-D 
model (also known as back-projection). When more than one raw image is aligned to a 
particular reference image then the raw images are averaged. 
 Figure 3.4    The basic steps in 3-D reconstruction using randomly orientated images of same object. 
(a) Raw 2-D images of object (b) known 3-D starting model (c) 2-D projections of the 
known starting model (d) Align 2-D raw images to the 2-D projections to obtain angular 
and transitional parameters. (e) back project a 3-D model using angular and transitional 
parameters obtained in the previous step.  (reproduced from lecture notes: 
http://people.cryst.bbk.ac.uk/~ubcg16z/cpn/uclEM2.pdf ) 
The workflow is then iterated (refinement) until no further improvement to resolution can 
be obtained with the extracted 2-D particle image set. Increasing the number of 
classification groups (angular refinement), may further improve the alignment of the 
images and thus increase the resolution of the 3-D back-projected volume. However, there 
is a concern that the starting model could introduce a bias towards the final model. To 
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overcome this concern, a strategy to independently group and align the macromolecule 
image set on the basis of their similarity in pre-determined number of classes is used. This 
technique is known as common lines, from which an initial model is generated from the 
created classes.  
Determining the resolution for single particle reconstructions (Liao & Frank, 2010) is 
obtained by splitting the images into two sets and looking for data consistency between the 
two independent reconstructions. Comparisons are made over rings (shells) with increasing 
radii in the Fourier space of the two models. The Fourier shell correlations (FSC) are 
plotted against their respective ring and a FSC threshold of 0.5 is used to quote the 
resolution obtained. 
3.2 Materials	  and	  Methods	  
Where no specific mention is made, the same protocol was applied to both negative stain 
samples. Visualizations of 3-D volumes and sub-atomic structures was done using the 
CHIMERA (Meng et al., 2006) software. 
3.2.1 Sample Preparation 
Recombinant PfGS was isolated from Escherichia coli using a cold shock expression 
protocol and purified as described in chapter 2. The stored protein was diluted to 
approximately 0.1 mg/ml with buffer5.  
3.2.2 Negative Stain Grid  
Electron microscopy grids that were pre-coated with thin carbon support film were glow 
discharged in air for 20 seconds. Four 10 µl droplets, one of 0.1 mg/ml of sample and three 
of 2% uranyl acetate solution were eluted on Parafilm™. The carbon-coated side of the 
grid was floated on the sample droplet for 25 seconds, before being lifted and blotted. 
Immediately the same side was floated on each of the remaining three droplets with 
blotting before moving on the next droplet. The grid was left floating for five seconds on 
each droplet. The grid was air dried at room temperature for 30 minutes, before storage in 
a closed Petri-dish awaiting microscope time. 
                                                
5 20 mM Na2HPO4 buffered to pH7.4 with NaH2PO4+ 50 mM NaCl + 5mM MnCl2  
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3.2.3 Negative stain EM Grid Imaging  
Micrographs were recorded, using a 4096 x 4096 slow scan CCD camera with 15 µm pixel 
size, attached to the TEM-F20 operated at 200 kV. Dosage was set at 20 e/Å2. Astigmatism 
and defocus were checked and manually adjusted after a change to a new location on the 
grid was made. The first image set was captured at a 50 000 x magnification and the 
second image set at a 100 000 x magnification setting on the TEM-F20 console. The 
calibrated sampling was 2.11 and 1.05 Å /pixel 
3.2.4 Micrograph Rejection and Contrast Transfer Function Parameter Estimation 
An initial screening was undertaken by visually inspecting the spatial frequency power 
spectrum of the micrograph and by rejecting those with Thon rings that indicated 
astigmatism or did not or a resolution of one quarter of the maximum for the magnification 
in question. Acceptable micrographs were then included in the reconstruction pipeline 
software for further processing. Estimated defocus, astigmatism and confidence of 
parameter fits for each micrograph was obtained using CTFFIND (Mindell & Grigorieff, 
2003) software which was further used to exclude low quality micrographs. 
3.2.5 Negative Stain Image Processing and 3-D Reconstruction 
The APPION web application software (Lander et al., 2009) was chosen for the 3-D 
reconstruction.  
3.2.5.1 Particle Selection and Image Stack Creation 
The expected particle size, as measured from a typical micrograph, was 160 Å (Figure 
3.5). With a practical maximum resolution of 15 - 20 Å expected from a negative stained 
sample for the reconstruction, sampling at 7.5 Å at a minimum was necessary to avoid 
aliasing and accumulating interpolation errors during reconstruction. With sampling at 
2.11 and 1.05 Å respectively, downsizing the image beyond a factor of 3 and 6 
respectively was avoided.   
For the first negative stain image set, an initial small set of particles were manually 
selected and classified into categories. These were then used as templates for auto-picking 
using the FindEM software (Roseman, 2004). For the second negative stain image set 
particles were all picked manually, due to the close proximity of the side view particles.  
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Particle extraction was done on phase-flipped micrographs and stacked, using the smallest 
recommended box size to minimise the possibility of incorrect alignment of the side views 
with adjacent particles.  
The first image set extraction was done at 112 pixels and for the second image set at 224 
pixels. The 224 box size particles were binned to 112 pixels. Images were padded to 160 
pixels during the alignment and reconstruction phases to avoid edge effects when 
transformations are carried out on the particle images.  
3.2.5.2 Particle Alignment 
Alignment of the stacked images were undertaken using the EMAN (Ludtke et al., 1999) 
protocol and unsupervised classification using the Xmipp (Pascual-Montano et al., 2001) 
software package. 
3.2.5.3 Ab Initio Model 
Due to the close proximity of the side views, constructing of an ab initio model using 
common lines was not practical. Having confirmed a six-fold symmetry from the first 
negative stain data set, filtering of a glutamine synthetase from PDB:1F52 to 50 Å was 
used as the starting model for refinement. Concerns of model bias are discussed in the 
section 3.4 
3.2.5.4 Model Refinement and Reconstruction 
The EMAN1 (Ludtke et al., 1999) projection-matching refinement protocol was used, 
whereby the extracted particles are classified according to the angular projections of the 
previously constructed model. Standard recommended parameters were used with a phase-
flipped particle set. No amplitude corrections were invoked.  
3.2.5.5 Post Processing of 3-D constructed model 
The final model was, however, low-pass filtered to 15A. 
3.3 Results	  
3.3.1 First Negative Stain Image Set 
3.3.1.1 Visualisation  
Inspection of the first negative stain images reveal roughly spherical particles (referred to 
 42 
 
Figure 3.5    A typical micrograph from the first negative stained image set. Spherical images only 
were visible. Shown above is (1024x1024 pixels extracted from the captured image of 
4096x4096 pixels).  
as top views). A micrograph in Figure 3.5 typifies this. Particle orientations were however, 
limited to these top (spherical) views measuring approximately 160 Å.  
3.3.1.2 Micrograph rejection based on FFT  
 Figure 3.6    Spatial frequency power spectra of a subset of 10 accepted micrographs. These 
micrographs were accepted due to near spherical Thon rings. The reference boxes indicate 12.5, 25 
and 37.5% of Nyquist frequency. 
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From the micrographs accepted for further processing, the power spectra of ten 
micrographs are shown in Figure 3.6. These power spectra indicate minimal astigmatism 
and Thon rings extending beyond the 37.5% Nyquist frequency (corresponding to a 
resolution of 5.6 Å). 
 Figure 3.7    Spatial frequency power spectra of a subset of 10 rejected micrographs. These 
micrographs were rejected due to non-circular or limited extension of the thon rings. 
Mic282 was obviously corrupted. The reference boxes indicate 12.5, 25 and 37.5% of 
Nyquist frequency. 
The power spectra of ten micrographs that were rejected for further processing are shown 
in Figure 3.7. Micrograph 282 was corrupted during image recording. Micrograph 178 
indicates drift whilst micrographs 48, 49 and 259 indicate limited spread of Thon rings. 
The remaining micrographs indicate unacceptable astigmatism. A total of 16 micrographs 
were rejected leaving 119 for further processing.  
3.3.1.3 Micrograph rejection based on CTF parameters  
  Min Max Average S/Deviation 
Average Defocus µm 0.49 3.10 0.84 0.22 
Astigmatism o (deg) 15.1 38.3 21.7 3.1 
Confidence  % 83.2 99.4 95.1 3.4 
Table 3.1     CTF parameter fit of the 119 accepted micrographs using the CTFFIND algorithm. 
Confidence levels average 95% with a standard deviation of 3.4%.  
Table 3.1 summarises the fitting of CTF parameters which indicate the range of 
astigmatism between 15° to 38° and a confidence of parameter fitting in the range 1/30 to 
1/10 Å, of between 83 and 99%. Confidence limits greater than 80% are considered 
acceptable. Based on these results, no further micrographs were rejected. 
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3.3.1.4 Auto-Picking of particles using Templates   
After selecting 73 particles manually, they were divided into four classes and used as 
templates for auto-picking.  
 Figure 3.8    The initial stack of the manually picked particles used for creating four templates.  
The 73 particles extracted, as shown in Figure 3.8, were classed into four groups, which in 
turn were used to auto pick particles from all the micrographs. Images of the four 
templates can be seen in section 1 of Appendix C. 
Figure 3.9 is a typical micrograph indicating the selection of particles by each of the four 
templates, by way of the four different colours.  
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 Figure 3.9    Typical micrograph after auto-picking of particles using the FindEM software embedded 
in Appion. The four colours (yellow, green, turquoise and blue) represent the template 
used as the basis for selecting the particular particle. 
A total of 29665 particles were selected using the default parameters and restricting the 
number of particles to 250 per image (the Appion GUI for template particle picking is 
shown in section 1.0 Appendix C). The selection of some touching particles could have 
been avoided by rerunning the auto picking with changed settings in the advanced options 
section. 
3.3.1.5 Particle Stack creation   
Phase flipping and CTF correction was applied at the micrograph level before particle 
extraction was made. Following the stack creation (the Appion GUI for particle stack 
creation is shown in section 2.0 Appendix C), further filtering based on mean and standard 
deviation of pixel values, was undertaken to reject the outlier images, resulting in a final 
stack of 28001 particles.  
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3.3.1.6 Reference Free Alignment 
The 28001 particles were aligned into twenty classes. The average of each class is shown 
in Figure 3.10 (the Appion GUI for creating reference free classes is shown in section 3.0 
Appendix C).  By inspection, it is clear that there is a lack of side view particle 
orientations. 
 Figure 3.10  Alignment of the 28001 particles into 20 reference free classes. Only near spherical 
reference free classes were created (top views). A full spectrum of orientations are 
required for 3-D reconstruction. 
However, a very important conclusion was made from undertaking a rotational cross 
correlation of 11th class, which is enlarged in Figure 3.11.  Visibly a six fold symmetry 
looks apparent. The result of the rotational cross-correlation on this class is indicated in 
Figure 3.12.    
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3.11  Reference free class image enlarged of class number 11 from Figure 3.10. 
 
Figure 3.12  Rotational cross correlation of the 11th class. The plot indicate peaks of the 
cross-correlation coefficient every sixty degrees. 
Cross-correlation values peak at sixty degree intervals as can be seen in Figure 3.12, is 
strongly indicative of a six-fold symmetry.   
3.3.1.7 Initial model and Reconstruction  
As side views were not represented in the data set, an initial model and reconstruction was 
not attempted with this data set.   
3.3.2 Buffer trials for EM Grid Preparation 
To enable reconstruction, side views of PfGS on the EM grid was essential. Different salt 
concentrations and glycerol concentrations were tried for negative stain grid preparations 
towards obtaining all orientations of the particle. 
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 Figure 3.13  Visualisation of EM grids prepared at 100 and 150 mM NaCl and glycerol at less than 
1% and 10%.  
Figure 3.1.3 indicates that increasing buffer salt concentration to 100 mM (from an initial 
50 mM) in the buffer, side views orientations became dominant but there was an absence 
of top views. The particles also appear to aggregate into different length ‘fibre’ like 
arrangements. Glycerol concentrations seem to have very little impact on particle 
orientation on the EM grid.  
Subsequent grid preparations were buffer exchanged to 100 mM salt concentrations and to 
less than one percent glycerol. Reducing particle concentration to 0.05 mg/ml and with a 
higher salt concentration of 100 mM was chosen to achieve both top and side orientations 
being represented.   
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3.3.3 Second Negative Stain Image Set 
3.3.3.1 Visualization  
Inspection of micrograph images recorded from the second negative stain grid revealed 
 Figure 3.14  Typical micrograph from second negative stain image set. EM grid prepared at 
100 mM NaCl and 50 μg/ml protein concentration. Both spherical and side views are 
visible (captured image on of 4096x4096 pixels) 
both side and top views being represented. This can be seen in a typical micrograph shown 
in Figure 3.14. This was achieved after altering buffer conditions in the phosphate buffer to 
100 mM NaCl and less than 1% glycerol and protein concentration to 50 μg/ml. Measure 
of the spherical particles is around 160 Å in diameter.  
3.3.3.2 Micrograph acceptance based on FFT  
Of the 319 micrographs that were recorded, a subset of 167, based on visually inspecting 
the power spectra of the micrographs, were accepted for further processing.  
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3.3.3.3 Micrograph acceptance based on CTF parameters  
  Min Max Average S/Deviation 
Average Defocus µm 0.44 0.88 0.56 0.09 
Astigmatism °(deg) 11.1 27.4 19.07 5.5 
Confidence 1/30 to 1/10 Å  % 97.2 99.9 99.3 0.5 
Table 3.2     CTF parameter fit of the 167 accepted micrographs using the CTFFIND algorithm. 
Confidence levels average 99% with a standard deviation of 0.5%.  
Table 3.2 summarises the fitting of CTF parameters which indicate the range of 
astigmatism between 11° to 28° and a confidence of parameter fitting in the range 1/30 to 
1/10 Å, of between 97 and 99%. Based on these results, no further micrographs were 
rejected. 
3.3.3.4 Manual Particle Picking  
Particles were manually selected and carefully centralized within the selection box.  
 
 
Figure 3.15  Manually picked particle on a typical micrograph. Selection of particles is unable to 
avoid overlapping between particles of side orientations. 
Selection of particles on a typical micrograph can be seen in the Figure 3.15. A total of 672 
particles were manually selected in this manner from the 167 micrographs that were 
accepted for further processing.  
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3.3.3.5 Particle Stack creation  
Phase flipping and CTF correction was applied at the micrograph level before particle 
extraction was made. Following the stack creation (the Appion GUI for particle stack 
creation is shown in section 4.0 Appendix C), further filtering, based on mean and standard 
deviation of pixel values, was undertaken to reject the outlier images resulting in a final 
stack of 663 particles.  
 Figure 3.16  A subset of particles extracted from the stack after manual picking. Note the adjacent particles in the images where side views are represented. 
A subset of 100 particles shown in Figure 3.16, indicates both top and side views. The side 
views are crowded with adjacent particles that will require tight masking during the initial 
reconstruction and refinement stages.  
3.3.3.6 Reference Free Alignment 
Of the thirty-six reference free class averages requested, (the Appion GUI for reference 
free alignment is shown in section 5.0 Appendix C) twenty seven were generated, as 
shown in the montage of the classes in Figure 3.17. Both top and side view orientations are 
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Figure 3.17  Reference free classes for second negative stain data set. Of the 36 classes requested, 
only 27 classes were outputted. Both circular views and side views are represented in the 
classes. 
represented in the 27 reference free classes computed. No further particle rejections were 
made at this stage due to the limited number of particles available for processing.  
3.3.3.7 Initial model 
It was not practical to generate a reference free model using common lines given the  
   Figure 3.18  Starting model PDB:1F52 filtered to 50 Å.The central image is referred to as the top 
view. The left and right hand images are side views.  
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adjacent particles in the side view orientations. It was decided to use, as a starting model, a 
homology PDB6 structure, filtered to 50Å to enable alignment of the side views. Three 
views of the filtered starting model filtered is shown in Figure 3.18. Concerns on model 
bias are addressed in the discussion section.  
3.3.3.8 Model Refinement  
The refinement was set for 20 iterations, using the EMAN (Guang Tang et al., 2007) 
projection matching refinement protocol. A D6 symmetry was imposed, together with 
angular sampling, and was set at 7.5° for the first 10 iterations and 5° for the next 10 
iterations (the Appion GUI for single particle reconstruction is shown in section 6.0 
Appendix C). 
  Figure 3.19  Model resolution converges vs refinement cycle.  
The results of the model resolution following each iteration, shown in Figure 3.19, indicate 
convergence in the first five iterations. The final model resolution after 20 iterations was 
16 Å. The number of particles used in the back projection during each iteration averaged 
576. 
The final model filtered to 15 Å, is shown in Figures 3.20 and alternate views in Figure 
3.21. On inspection, there is a central density occurring in the final reconstruction, which is 
attributed to the tightness of adjacent particles that was not avoided in the side views and 
was used for the reconstruction. 
                                                
6 Protein Data Base structure PDB:1F52 – Glutamine synthetase of Salmonella typhimurium 
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Figure 3.20  Top view of PfGS 3-D reconstruction filtered to 15 Å. The central density is attributed to 
tightness of adjacent particles that was not avoided in the side views and was used for the 
reconstruction. 
   Figure 3.21  Different views of the final reconstructed model. The center image shows a 45o rotation 
on the y-axis. The left and right hand images are side views. 
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3.4 Discussion 
3.4.1 Model Bias 
In order to put aside any suspicion of a model bias being introduced by using a PDB 
starting model, alignment of the first negative strain particle stack was made to projections 
of the final constructed model, using the second negative stain particle stack. Projections at 
three degree intervals resulted in a total of 179 projections of the model after applying a 
D6 symmetry.  
 Figure 3.22  Particle orientation distribution of the first negative stain data set.  
Summarizing the number of particles graphically in Figure 3.22 in three degree intervals of 
theta7, confirms the bias towards top views.  
Visual comparisons are made of the class averages of the first negative stain data set to the 
model projection in Figure 3.23 below.  
 
 
                                                
7 based on the Euler angle convention used in the Spider functions. 
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        0,0,0 (418) 0,3,0 (576) 0,6,0 (1052) 0,9,0 (1314) 0,12,0 (1394) 0,3,14.3 (454) 0.6,14.3 (943) 0,9,14.3(1297) 
         
        0,12,14.3 (1379) 0,15,0 (1187) 0,18,0 (1119) 0,21,0 (819) 0,24,0 (689) 0,27,0 (433) 0,15,14.3 (1119) 0,18,14.3 (726) 
         
       0,24,25.7 (941) 0,27,22.5 (230) 0,30,0 (223) 0,33,0 (166) 0,36,0 (104) 0,39,0 (59) 0,42,0 (35) 
       Figure 3.23  Model reference projections against class averages. Between the pair of images of each 
class and its model reference projection is shown the Euler angles used in Spider 
functions and the number of particles in the class. 
Visually there is a close resemblance in each of the classes to the reference model 
projection, which is indicative that model bias was not introduced to the structure 
resolution due to the use of a PDB starting model, which was used to aid the initial 
alignment of particles. 
3.4.2 Model Resolution using Fourier Shell Correlation 
The marginal increase of FSC values as can be seen in Figure 3.24 towards the Nyquist 
frequency, is indicative of some reconstruction artifacts. In the context of this 
reconstruction, tight masking was essential, and this phenomenon can be expected at the 
higher frequencies.  Given the relatively marginal increase observed, the resultant 
resolution obtained may marginally be over-estimated. 
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 Figure 3.24  FSC plot of the final 3-D construction.  
Using the practice of FSC at 0.5, the overall resolution of the reconstruction is 16 Å,  
3.4.3 Negative Stain inherent Limitations 
In the preparation of the EM grid, there is deposition of the stain over the specimen 
(protein). The resulting dehydration may result in flattening of the specimen (protein). This 
may result in the diameter of the molecule being overestimated. Hence using the density of 
the negative stain 3-D reconstruction volume for fitting any homology model will have a 
similar impact.  
3.4.4 Homogeneity of PfGS produced by the Purification Protocol 
The resulting reconstruction to a dodecamer is indicative of the single step purification 
protocol being robust enough to be used for further structural studies.   
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Chapter	  4	  –	 Homology	  Modelling	  and	  Docking	  
4 HOMOLOGY MODELLING AND DOCKING 
This chapter describes the basis for the prediction of PfGS structure and the docking of this 
predicted structure in the 3-D reconstructed volume in the previous section. Multiple 
alignments of PfGS with other GS depositions in PDB are also indicated. 
4.1 Introduction	  
The purpose of Homology Modelling is to be able to extrapolate an atomic resolution 
structure from an associated structure for a known protein sequence that has been 
previously solved. With the increasing availability of experimental structural data for 
diverse protein families, the predictive (extrapolative) models are constantly being 
enhanced. In general, the higher the sequences similarity of the gene of interest to the 
known atomic structure, the higher the confidence of the possession of similar structures. 
As a rule of thumb, more than a 30-percentage point sequence similarity between the gene 
of interest and a known atomic structure, for sequences of more than 250 amino acids, may 
produce meaningful structure prediction. 
Additionally, success also depends on the extent of gaps and insertions between the protein 
of interest and the template sequence alignments. However, dealing with gaps/insertions 
greater than eight in a particular domain can be very challenging. 
4.2 Methods	  
4.2.1 Automatic Model Prediction 
The PSIPRED (Buchan et al., 2013) server was used for structure prediction using the 
BioSerf 2 automated homology modelling protocol and visualization of the model in 
CHIMERA (Meng et al., 2006). 
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Figure 4.1    Flowchart of the BioSerf2 automated homology modelling protocol.Incoming query 
sequences are independently matched to PDB chains using PSIBLAST and 
pGenTHREADER and HH. The three sets of models produced are then compared by 
TMJury process, which produces up to 10 candidate homologous structures. These 
structures are their alignments to the query sequences and are used as input for 
MODELLER to produce a single final model. (Reproduced from  Buchan et al. (2013)) 
The BioSerf2 automated protocol as explained in Figure 4.1, also outputs the 
pGenThreader (Lobley et al., 2009) and PSIPRED (Jones, 1999) scoring which is used to 
recognise the closest structural homologs and secondary folding probabilities during the 
computational protocol. 
The predicted model was also independently validated using programs ProSA (Sippi,  1993 
& Wiederstein, et al., 2007) and Verify-3D (Bowie, et al., 1991 & Luethy, et al., 1992).  
ProSA compares the predicted model to current PDB models deposited in PDB and an 
energy plot as a function of sequence position. Problematic parts of the model can then be 
identified based on residues that show up as positive energy levels. Verify-3D on the other 
hand attaches to each residue three attributes obtained from the query 3D protein structure. 
These are:  
i) the  total area of the side chain area covered by other protein atoms 
ii) the fraction of the side chain area that is covered by polar atoms 
iii) the local secondaty structure. 
A composite score, referred to as 3D-1D score for each position of the query sequence is 
calculated. Using the 3D-1D scores in the Veryfy-3D algorithm in a moving-window scan 
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against the database of known sequences is able to identify incorrectly modeled segments 
when the compatibility score is below 0.2. 
4.2.2 Multiple Sequence Alignments with PfGS 
Multiple sequence alignments were done on the EMBL-EMI server using Clustal W 
(Larkin et al., 2007).  
4.2.3 Docking the Predicted PfGS Model into the 3-D Resolved EM Map of PfGS 
Rigid docking of the model was undertaken using two of the Situs (Wriggers, 2010) 
functions,   
• “colores” to dock the monomer to the reconstructed 3-D map 
• “pdbsymm” to construct the macro-molecule to a D6 symmetry.  
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4.3 Results	  
4.3.1 Secondary Fold Predictions and Confidence Scores 
 Figure 4.2    PSIPRED Protein fold predictions for PfGS outputted using the BioSerf2 protocol. The 
confidence levels of the predicted fold are indicated by the blue bar above each amino 
acid (Reproduced from BioSerf2 output) 
All fold predictions, as indicated in Figure 4.2, have a high level of confidence except for 
three zones between 299-306, 361-369 and 449-458. 
4.3.2 Structural Homolog Predictions and Scoring 
The outputs of the three highest scoring structural alignments from pGenThreader are 
indicted in Table 4.1. Reporting of p-value statistic in column 3 is compared to the 
traditional threshold value less than 0.05 as a significant result is indicated in column 1.  P-
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GenTHREADER classifies a p-value of less than 0.00001 as CERT., less than 0.001 as 
HIGH and less than 0.01 as MEDIUM.  
 
Table 4.1     Top three scoring organisms from pGenTHREADER blast. Namely, PDB:3NG0 
(Synechocystis sp), PDB:1F52 ( Salmonella Typhimurium) and PBD:4ACF 
(Mycobacterium tuberculosis) (Reproduced from BioSerf2 output) 
The top three structures reported from the pGenTRHEADER scoring all have a p-value 
score less than 8 x 10-17 indicative of a good structural similarity. Synechocystis sp (PDB 
3NGO) having the highest score at 7 x 10-18, was used for visualisation and comparative 
purposes.  
Pairwise and Solvation energy scores are indicated in column 4 and 5 respectively. 
Pairwise alignment scores, the length of the alignment and the length of the structural hit 
are shown in the next three columns. Column 9 indicates the query sequence length (PfGS 
in this case).  The button in the View Alignment column links out to enable viewing an 
annotated alignment. 
4.3.3 Structure Prediction  
The structure predicted from the BioSerf2 protocol for PfGS is depicted in Figure 4.3 as 
visualized in CHIMERA. 
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Figure 4.3    PfGS predicted model visualized in CHIMERA.  
Comparing the structure folds in the predicted model of the monomer and the expected 
secondary fold predictions of PSIPRED, it was found to be in agreement. 
4.3.4 Predicted Structure Validation 
Using ProSA the predicted model scores Z= -5.66, which falls within the range of scores 
derived from PDB structures of similar number of residues as shown in figure 4.4 
 
Figure 4.4    PfGS predicted model Z-score indicated against PDB deposited structures derived from 
X-ray crystallography and NMR techniques.  
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The energy plot averaging 20 residues on either side of the sequence position, indicates 
 
Figure 4.5    PfGS predicted model energy plot (average of 40 residues) indicates two problematic 
zones as highlighted in the figure. 
two problematic zones as highlighted in figure 4.5. These zones co-incide with the two 
large insertion loops as identified in the sequence alignment with type 1 glutamine 
synthetases’ in figure 4.8. 
Verify-3D scores for 3D-1D averaged scores below 0.2 are considered problematic.   
 
Figure 4.6    PfGS predicted model 3D-1D Averaged scores plotted against residue sequence 
Verify-3D results for the predicted PfGS also confirms the two zones with the large 
insertions to be problematic. Two further zones centered at residue 44 and 380 using the 
Verify-3D methodology are also identified as problematic. The problematic zones are 
highlighted in figure 4.7. 
The Ramachandran plot, as indicated in figure 4.8, shows bulk of the residue phi and psi 
angles were within the core area and more than 90% of all residues being within the  
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Figure 4.7    Ramachandran plot of PfGS predicted model. Core areas indicated in red and acceptable 
areas in yellow. Glycines indicated as “+”. 
allowed area. Whilst this in itself does not prove that the predicted model is robust, it is 
however, indicative of a model with conformational stability. 
4.3.5 Multiple Sequence Alignment scores of PfGS against GS PBD Depositions 
GS	  
Type	   Deposition	  
Chain	  
Length	   Organism	   PfGS	  
II	  
4BAX	   344	   Streptomyces	  Coelicolor	   9	  
4IS4	   378	   Medicago	  truncatula	   6	  
2OJW	   384	   Human	   9	  
2D3A	   356	   Zea	  	  Maize	   5	  
3FKY	   370	   Saccharomyces	  cerevisiae	   10	  
2UU7	   381	   Canis	  Familiaris	   10	  
I	  
4LNI	   443	   Bacillus	  	  subtilis	   30	  
1F52	   468	   Salmonella	  Typhimurium	   34	  
3NG0	   479	   Synechocystis	  sp	   34	  
4ACF	   486	   Mycobacterium	  tuberculosis	   32	  
?	   n/a	   543	   Plasmodium	  falciparum	   -­‐	  
III	   2O6X	   729	   Bacteroides	  fraglis	   10	  
Table 4.2     Multiple alignment scores of PfGS against other PDB depositions for glutamine 
synthetase using Clustral W.  
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The multiple alignment scores in Table 4.2 indicate that PfGS has greater than 30% 
similarity to GS I and less than 10% to the other two GS types. A multiple alignment of 
PfGS with the four GS I sequences is indicated the Figure 4.4.  
 Figure 4.8    PfGS multiple sequence alignment with GS I PBD depositions. The five conserved 
regions are indicated according to the following colour key: Red=Region1 – Latch; 
Brown=Region2 – Enzyme Active Site; Magenta=Region3 ATP binding site; 
Green=Region4 Glutamate Binding Site; Blue=Region5 Enzyme Active Site and 
Grey= Adenylylation Loop (adapted from Clustal W output) 
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The multiple alignments in Figure 4.4 clearly indicate the two large insertion areas in PfGS 
compared to the other GS I sequences. The second insertion area is in the vicinity of the   
adenylylation loop (residues 412 to 482) with PfGS having three tyrosine residues in this 
vicinity. GS I with conserved adenylylation loop has a single tyrosine residue in this 
vicinity. This observation may indicate that PfGS activity is not inhibited by adenylylation.  
4.3.6 Rigid Docking of Predicted Model 
The outcome of docking the predicted model in the 3-D reconstructed model is indicated in 
Figures 4.9 to 4.11. 
 
Figure 4.9    Top view of the rigid docking of predicted PfGS model using Situs functions. The 
reconstructed density does not cover a substantial length of the inner loop of the 
predicted model. 
The reconstructed 3-D model density, as can be seen in Figure 4.5, does not cover the inner 
loop of the predicted model fully.  Unoccupied density cannot be located in the vicinity 
from this view. The rest of the visible predicted structure is contained within the 
reconstructed density. 
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Figure 4.10   A side view of the rigid docking indicates the reconstructed density does not cover a   
substantial length of the outer loop of the predicted model.  
The reconstructed 3-D model density, as can be seen in Figure 4.6, does not cover the outer 
loop of the predicted model fully.  Unoccupied density from this view cannot be located in 
the vicinity of the loop. The rest of the visible predicted structure is contained within the 
reconstructed density. 
 
Figure 4.11   Another view of the rigid docking better indicating some unoccupied density in the 
vicinity of the outer loop. 
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A slightly different view of the docking in Figure 4.7 indicates some unoccupied density in 
the vicinity of the outer loop. However, this density is unlikely to account for the total 
visible length of the outer loop in the predicted model.   
4.3.7 Surface interactions 
Four subunits of the PfGS predicted model are docked in Figure 4.12, indicate that the  
 Figure 4.12   Four subunits docked in the 3-D reconstruction indicate that the macromolecule is held 
together in a similar manner as GS I.  
surface interactions that hold the macromolecules together are similar to that of GS I. The 
subunits are held together in a ring by heterologous contacts (red-blue and green-yellow 
sub-units in Figure 4.8) while the C-terminal helices make isologous contacts (green-red 
and yellow-blue in Figure 4.8) to bind the two rings together. In the case of the first 
crystallized GS III, van Rooyen, et al. (2011) surprisingly showed the N-terminal helices 
make the isologous contact between the rings.   
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4.3.8 Visualisation of Predicted model against PDB:3NGO 
Visualisation in Chimera of the homolog PDB-3NG0 to the predicted PfGS structure is 
shown in Figure 4.9. 
 
Figure 4.13  Visualisation of the PfGS predicted model aligned to PDB-3NG0. The conserved regions 
have been highlighted in different colors. The significant larger inner and outer loops for 
PfGS have also been indicated. 
The inner loop shows itself up at the center of the macromolecule while the outer loop 
shows itself at the outer periphery of the macromolecule at the intersection of the two half 
rings. This is apparent in the docking images in Figure 4.5 to Figure 4.7. 
The overall RMSD between the predicted PfGS model, without the two insertions and the 
PDB:3NG0 structure is 0.6 Å, which is indicative of a very close structural alignment with 
the rest of the structure. Similar RMSD’s were obtained with the other two high similarity 
PDB structures, 1F52 and 4ACF. Whilst the homology model is not a substitute for a 
crystal structure, early indications from the docking of the homology model suggests that 
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PfGS would be similar to a GS I structure, but with two larger flexible loops. In this 
regard, it can be expected that the structure function, as reviewed by Eisenberg et al. 
(2000), and summarized in section 1.2.5.3, would be applicable to PfGS.   
4.3.9 Active Site Positioning at the Heterologous Interface 
 
Figure 4.14  An increased threshold level of the 3-D volume density creates an opening in the vicinity 
of the two sub-unit interface.  
In Figure 4.10, the threshold of the 3-D reconstructed volume density was increased, 
creating an opening on the volume map in the vicinity of the sub-unit interface, which also 
locates the active site entrance.  
4.3.10 Visualisation of Active Site Relative to Mycobacterium tuberculosis GS and 
Canis familiaris GS (as proxy for Human GS) 
The Canis familiaris was used as a proxy for the Human GS on the basis of a 96% 
sequence similarity score (Table 1.4) and Mycobacterium tuberculosis, PDB:2BVC was 
chosen to leverage the extensive functional studies undertaken by Eisenberg et al. (2000). 
Each sub-unit of GS from the respective organisms was aligned with the adjacent subunit 
assuming a resultant position (Fig 4.12) as positioned on the respective macromolecule.  
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i Figure 4.15  PfGS homology model alignment to M.tuberculosis GS and C.familiaris GS. Sub-unit A 
is used for the alignment, making subunit B resultant based on the respective 
macromolecule position. 
 Figure 4.16  Active site PfGSpredicted model against Mycobacterium tuberculosis, PDB:2BVC and 
Canis familiaris PDB:2UU7. The active site is completed by three amino acids from the 
adjacent monomer, indicated by B1,B2,B3. Colour Key: Red=Ligands; Green= Canis 
familiaris GS; Hot Pink= Mycobacterium tuberculosis GS; Blue=PfGS. Ligands shown 
are ADP and P3S. The cations have been excluded for clarity. 
 73 
The active site zoomed in to show the side chains for PfGS are indicated in Figure 4.12, 
against the Mycobacterium tuberculosis, PDB:2BVC and Canis familiaris PDB:2UU7 
structures.  
Three amino acids, two serine and one aspartic acid from the adjacent sub-unit complete 
the active site. The RMSD for each of the conserved active site amino acids is shown in 
Table 4.3. 
Conserved  Plasmodium falciparum 
Canis 
familiaris 
Mycobacterium 
tuberculosis (1) - (2) (3) – (2) (4) – (5) 
 (1) (2) (3) (4) Å (5)  Å  Å 
A1 E-­‐137	   E-­‐134	   E-­‐133	   0.642	   0.525	   0.1	  
A2 E-­‐139	   E-­‐136	   E-­‐135	   0.352	   0.455	   0.1	  
A3 Q-­‐240	   A-­‐191	   E-­‐214	   2.262	   2.639	   0.4	  
A4 Q-­‐241	   G-­‐192	   K-­‐215	   1.704	   1.837	   0.1	  
A5 E-­‐245	   E-­‐196	   E-­‐219	   0.369	   0.452	   0.1	  
A6 E-­‐252	   E-­‐203	   E-­‐227	   0.819	   0.781	   0.0	  
A7 S-­‐254	   Q-­‐205	   N-­‐229	   1.725	   1.843	   0.1	  
A8 Y-­‐257	   P-­‐208	   F-­‐232	   1.094	   0.955	   0.1	  
A9 H-­‐301	   H-­‐253	   H-­‐276	   0.307	   0.507	   0.2	  
A10 N-­‐303	   N-­‐255	   H-­‐278	   0.238	   0.39	   0.2	  
A11 S-­‐305	   S-­‐257	   S-­‐280	   0.354	   0.112	   0.2	  
A12 R-­‐355	   R-­‐299	   R-­‐329	   0.149	   0.238	   0.1	  
A13 E-­‐361	   E-­‐305	   E-­‐335	   0.819	   2.264	   1.4	  
A14 R-­‐373	   R-­‐319	   R-­‐347	   0.189	   1.052	   0.9	  
A15 R-­‐378	   R-­‐324	   R-­‐352	   0.51	   0.788	   0.3	  
A16 R-­‐391	   Y-­‐336	   R-­‐364	   0.408	   0.504	   0.1	  
A17 E-­‐393	   E-­‐338	   E-­‐366	   0.182	   0.248	   0.1	  
A18 R-­‐395	   R-­‐340	   R-­‐368	   0.108	   0.287	   0.2	  
B1 D-­‐59	   D-­‐63	   D-­‐54	   1.448	   1.473	   0.0	  
B2 S-­‐61	   S-­‐65	   S-­‐56	   3.544	   1.839	   1.7	  
B3 S-­‐62	   S-­‐66	   S-­‐57	   4.032	   0.899	   3.1	  
Table 4.3     RMSD of the conserved active site amino acids relative to Canis familiaris. 
The PfGS and Mycobacterium tuberculosis GS share very similar RMSD of the conserved 
active site amino acids with Canis familiaris. The PfGS, has a significantly larger RMSD 
on two of the conserved active sites on the adjacent sub-unit than Mycobacterium 
tuberculosis GS  by 1.7 and 3.1 Å .  
4.4 Discussion	  
Using the BioSerf2 automated protocol provided a homology model with significantly high 
scores. Rigid docking of the homology model showed that two of the loop zones were not 
contained in the negative stain EM 3-D reconstructed volume. PfGS has two large 
insertions not found in any of the GS I structures. Structurally, the two insertions are 
located in the vicinity of the loops also found in GS I structures, referred to as the inner 
and outer loop. The inner loop shows itself up at the center of the macromolecule while the 
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outer loop shows itself at the outer periphery of the macromolecule at the intersection of 
the two half rings of the macromolecule. This is apparent in the docking images in Figure 
4.6 to Figure 4.8.  
The overall RMSD between the predicted PfGS model, without the two insertions and the 
PDB:3NG0 structure is 0.6 Å, which is indicative of a very close structural alignment for 
the rest of the structure. Similar RMSD’s were obtained with the other two high similarity 
PDB structures, namely 1F52 (Salmonella Typhimurium GS) and 4ACF (Mycobacterium 
tuberculosis GS). With such close RMSD’s it can be expected that the structure function as 
reviewed by Eisenberg et al. (2000), and summarized in section 1.2.5.3, would be 
applicable to PfGS.   
However, there was no unoccupied density of sufficient magnitude in the respective 
vicinities of the loops to occupy the full length of the predicted loops. The loci of these 
loops are likely to span a large volume and occupy random spatial orientations, thus 
increasing the possibility of not locating sufficient density to be seen on the 3-D 
reconstruction. More particles than used in this study for the 3-D reconstruction may locate 
the density for these loops. Homology modeling does not enable the structure of large 
inserted loops to be predicted as shown by the ProSA and Verify-3D algorithms that 
demonstrate poor structures in these parts of the molecule. Furthermore, the loops may not 
fold into a single structure because the density available in the 3D reconstruction is 
insufficient to accommodate the entire loops indicting the possibility of disorder. 
The RMSD’s for the active site residues between the Human GS and the homology PfGS 
ranges from 0.1 to 4.0 Å. The largest RMSD is found on the two residues of the adjacent 
chain, completing the active pocket of 3.5 and 4.0 Å. The marginally larger PfGS 
macromolecule as indicated (Figure 4.13), probably results in the higher RMSD.  
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Figure 4.17  Relative size of the GS macromolecules, PfGS reconstructed, Mycobacterium 
tuberculosis, PDB:2BVC and Canis familiaris PDB:2UU7. Canis familiaris has a D5 
symmetry whilst Mycobacterium tuberculosis and PfGS have a D6 symmetry. 
for these two active site residues. This result could be negated if the extent of flattening of 
the specimen was significant due to the staining dye. Confirming the higher RMSD 
indicated by the homology model, with either Cryo-EM or X-Ray crystallography would 
provide information for targeting the glutamate analogues for PfGS as a novel drug target, 
as opposed to most of the screening for new drug targets for Mycobacterium tuberculosis 
GS which is based on ATP analogues where the RMSD’s of the active sites are the 
smallest when compared to the human GS.   
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5  
5.1 Summary	  
The completion of the Plasmodium falciparum genome enabled synthesizing of glutamine 
synthetase. The expression of PfGS was achieved by cloning the synthesized gene using a 
commercially available expression plasmid and transformed into an Escherichia coli strain.  
Purified PfGS was eluted using chromatography and making use of competitive binding. 
PfGS was stabilized using Mn++ cations before concentrating the macromolecule to 2 
mg/ml.  
Both side and top views of the PfGS macromolecule on the negative stain electron 
microscope grids were achieved at 100 mM salt concentrations with the protein at 50 μg/ml concentration. Single particle reconstruction required the use of tight masking in the 
alignment step, to minimise the impact of adjacent particles that were in close proximity. 
Current approaches in bioinformatics provided the basis for recognizing the conservation 
of the active sites and a high confidence for the generation of an homology model.  
5.2 Study	  Limitations	  
PfGS crystal trials were conducted with Hampton standard screens HR2-110 & HR2-112 
and samples were also sent to ICGEB, Delhi, India for use on their nano-litre pipetting 
robot (Mosquito) , enabling hi-speed screening. No PfGS crystals resulted from over 3000 
conditions that were tested.  
The large loops on the negative stain 3-D reconstruction was not fully located and 
subsequently precluded flexible docking of the homology model. The 3-D reconstruction 
was computed with a limited number of particles (576) and with side views that were 
adjoined. This required tight masking for particle alignment, which may have introduced 
some artifacts at high resolution. In addition large loops are not reliably modeled by the 
tools available and have also been independently validated accordingly in the vicinity of 
the loops. Both side chain orientations and loop structures would be best handled with high 
resolution Cryo-EM 3D reconstruction with a large number of particles used in the 
reconstruction 
Negative staining is known for flattening of the biological specimen due to the deposition 
of the stain onto the specimen. The impact of this may have resulted in the size of the 
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molecule being overestimated and therefore having an impact of the RMSD’s that were 
calculated in chapter 4. 
These limitations can be avoided by obtaining sub-atomic resolution of 3-D reconstruction 
of PfGS.  
5.3 Technical	  Achievements	  
Soluble PfGS was expressed using a cold shock vector (pCold I (Takara) in Escherichia 
coli (strain BL21 (DE3)). Ni-affinity chromatography provided purified PfGS in a single 
step due to the binding affinity of the attached histidine tag to the PfGS. Screening of the 
fractions of the purified PfGS indicated the presence of active GS. 
Purified PfGS was not stable at room temperature and was stabilized with the addition of 
manganese cations and forward reaction ligands, namely ATP and glutamate. A 
concentration of 8 mg/ml of PfGS was achieved with the addition of 0.4 mM beta-octyl 
glucoside enabling crystal trial screening. 
A 3-D reconstruction of PfGS with a resolution of 16 Å was enabled using tight masking 
for particle alignment.    
5.4 Scientific	  Achievements	  
The quartnernary structure of PfGS was unequivocally demonstrated.. Twelve mononmers 
are arranged in two six-membered rings that are stacked back-to-back, resulting in a 
comple with D6 symmetry. 
PfGS has significant homology with GS I structures with the exception of two large 
insertions. One insertion is located in the central core of the rings – no unoccupied density 
was found for this insertion suggesting that it is disordered. The other insertion is 
externally located in a region of the map that has unoccupied density. The volume of the 
unoccupied density is insufficient to accommodate the full insertion indicating that part of 
it is disordered. The otherwise significant conservation indicates the presence of a common 
core folding and the conservation of the active sites. Both the multiple sequence alignment 
and structural alignment indicate that PfGS is unlikely to have a conserved adenylylation 
loop.  
With both the active sites in PfGS found to be conserved structurally, the targeting of these 
active sites with their respective analogues is therefore not precluded.  
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5.5 Future	  Direction	  
The study has determined the conditions for the expression and purification of soluble 
active PfGS. The protein prepared is suitable for structure determination by 3D-EM. 
Further structural function studies should employ high resolution cryo-EM using direct 
electron detectors and/or X-ray crystallography. In my opinion X-ray crystallography may 
not be the technique of choice for high resolution structure determination of PfGS because 
of the presence of the apparently disordered, externally located loop. If further detail were 
obtained by cryo-EM studies a crystallizable clone might be prepared by excision of the 
loop. 
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Appendix	  A	  –	  Growth	  Media,	  Stock	  Solutions	  and	  Buffers	  	  
Water used was purified using the Milli-RP Plus (Millipore) system, abbreviated as dH2O. 
1.	  	  	  Growth	  Media	  – All media and solutions were autoclaved at 121°C for 20 minutes. 
	  	  	  	  	  	  	  	  	  	  	  1.1.1	  	  	  	  	  Luria	  broth	  (LB)	  
Tryptone  10 g 
Yeast extract 5 g 
NaCl 5 g 
dH2O to 1 L 
	  	  	  	  	  	  	  	  	  	  	  1.1.2	  	  	  	  	  	  Luria	  agar	  (LA)	  
Tryptone 10 g 
Yeast extract 5 g 
NaCl 5 g 
Agar 15 g 
dH2O to 1 L 
2.	  	  	  Stock	  solutions	  
	  	  	  	  	  	  	  2.1	  	  	  Antibiotic	  solutions	  –	  Dissolve and filter sterilize mixture. Store in 1 ml 
eppendorfs at -20°C until required. 
                 2.1.1	  	  	  	  	  	  Ampicillin	  –	  100	  mg/ml	  
ampicillin 1 g 
dH2O to 10 ml 
                 2.1.2	  	  	  	  	  Kanamycin	  –	  25	  mg/ml	  
kanamycin 0.5 g 
dH2O to 10 ml 
	  	  	  	  	  	  	  2.2	  	  	  General	  Buffers	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.2.1	  	  	  	  	  Na2HPO4	  (20	  mM)	  
Na2HPO4(anhydrous) 5.68 g 
dH2O to 2 L 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.2.2	  	  	  	  	  Na2HPO4	  (20	  mM)	  
NaH2PO4.H2O 5.52 g 
dH2O to 1 L 
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  2.2.3	  	  	  	  	  Sodium	  Phosphate	  Buffer	  20	  mM	  pH	  7.5	  -­‐ Check pH of mixture and 
adjust by addition of NaH2PO4 (20 mM) to increase pH and NaH2PO4 
(20 mM) to decrease pH. 
NaH2PO4 (20 mM) 810 ml 
NaH2PO4.H2O (20 mM) 190 ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.2.4	  	  	  	  	  Cell	  re-­‐suspension	  buffer	  50	  mM	  NaCl	  
NaCl 0.29 G 
Sodium Phosphate Buffer to 100 ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.2.5	  	  	  	  	  Protein	  buffer	  50	  mM	  NaCl;	  5	  mM	  Mn++	  
NaCl 0.29 g 
MnCl2 0.063 g 
Sodium Phosphate Buffer to 100 ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.2.6	  	  	  	  	  Optional	  Protein	  buffer	  50	  mM	  NaCl;	  5	  mM	  Mn++;	  5mM	  ATP;	  5mM	  Glu	  
NaCl 0.29 g 
MnCl2 0.063 g 
ATP 0.25 g 
Glu 0.07 g 
Sodium Phosphate Buffer to 100 ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.2.7	  	  	  	  	  EDTA	  0.5M	  -­‐ Dissolve both EDTA and NaCl in 400 ml OF dH2O, adjust 
pH to 8.0 with HCl and adjust to final volume of 500 ml. 
EDTA 93.05 g 
NaCl 10 g 
dH2O to 500 ml 
                 2.2.8	  	  	  	  	  	  Tris-­‐HCl	  1M	  -­‐ Dissolve Tris in 80 ml dH2O and adjust pH using HCl to 
required level and make up to final volume of 100 ml. 
Tris 12.1 g 
dH2O to 100 ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.2.9	  	  	  	  	  TE	  Buffer	  	  
Tris-HCl 1M pH 7.6 1 ml 
EDTA 0.5M pH 8 200 µl 
dH2O to 2 ml 
3.	  	  	  Agarose	  Gel	  buffers	  and	  Solutions	  
                 3.1.1	  	  	  	  	  	  TAE	  (Tris-­‐Acetate)	  x	  50	  
Tris 242 g 
EDTA 37.2 g 
Glacial Acetic Acid 57.1 ml 
dH2O to 1 L 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3.1.2	  	  	  	  	  EtBr	  (Ethidium	  Bromide)	  solution	  -­‐ Work must be carried out in fume 
hood and stored in dark bottle.  
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EtBr 0.1 g 
dH2O to 10 ml 
4.	  	  	  SDS-­‐PAGE	  Buffers	  and	  Solutions	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4.1.1	  	  	  	  	  SDS	  (Sodium	  Dodecycl	  Sulphate)	  10%	  -­‐ Dissolve SDS in 80 ml on hot 
plate without boiling, Make up to final volume of 100 ml.  
SDS 10 g 
dH2O to 100 ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4.1.2	  	  	  	  	  Resolving	  Gel	  Buffer	  -­‐	  	  Dissolve Tris in 80 ml dH20 and adjust to pH 8.8 
with HCl. Make up to final volume of 100 ml. 
Tris 18.17 g 
dH2O to 100 ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4.1.3	  	  	  	  	  Resolving	  Gel	  Buffer	  -­‐	  	  Dissolve Tris in 40ml dH20 and adjust to pH 6.8 
with HCl. Make up to final volume of 50 ml.	  
Tris 3.03 g 
dH2O to 50 ml 
                 4.1.4	  	  	  	  	  Running	  Buffer	  
Tris 3 g 
Glycine 15 g 
SDS 1 g 
dH2O to 1 L 
                 4.1.5	  	  	  	  	  	  Sample	  application	  Buffer	  x5 – Adjust pH to 6.8 with HCl 
Tris 3.8 g 
SDS 3 g 
Glycerol 10 ml 
B-mercaptoethanol 5 ml 
Bromophenol Blue 5 mg 
dH2O to 20 ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4.1.6	  	  	  	  	  Coomassie	  blue	  staining	  solution	  
Methanol 250 ml 
Acetic acid 50 ml 
Coomassie Blue R250 0.5 g 
dH2O to 500 ml 
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  4.1.7	  	  	  	  	  Destain	  solution	  
Ethanol 250 ml 
Acetic acid 100 ml 
dH2O to 1 L 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4.1.8	  	  	  	  	  Resolving	  Gel	  10%	  -­‐ Temed to be added just prior to loading gel slide 
Resolving gel buffer 2.5 ml 
Acrylamide mix (Promega) 3.33 ml 
SDS 10% 100 µl 
APS 10% 100 µl 
Temed 10 µl 
dH2O to  10  ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4.1.9	  	  	  	  	  Stacking	  	  Gel	  – Temed to be added just prior to loading gel slide 
Stacking gel buffer 1.25 ml 
Acrylamide mix (Promega) 0.625 ml 
SDS 10% 50 µl 
APS 10% 50 µl 
Temed 5 µl 
dH2O to  5  ml 
5.	  	  	  Ni-­‐Afffinity	  Elution	  Buffer	  -­‐  Elution buffers are vacuum filtered to 0.22 micron  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5.1.1	  	  	  	  	  Elution	  buffer	  A	  
NaCl 29.2 g 
Protein buffer to 1 L 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5.2.2	  	  	  	  	  Elution	  buffer	  B (0.5 mM Imidazole) 
Imidazole 34.04 g 
NaCl 29.2 L 
Protein buffer to 1 L 
   
6.	  	  	  γ-­‐glutamyl	  transferase	  assay	  (GGT)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6.1	  1	  	  	  	  	  Reaction	  Mix	  – Prepare stock solution of each reagent and make 
reaction mix for use within 12 hours and keep at 4°C. 
Imidazole-HCl 1 M pH7.15 329.4 µl 
Hydroxylamine hydrochloride 0.8 M 54.2 µl 
MgCl2 0.1 M 6.6 µl 
Potassium arsenate 0.28M pH 7.15 291.5 µl 
ADP 40 mM 22.0 µl 
dH2O  1321.3 µl 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6.2.1	  	  	  	  	  Glutamate	  0.2	  mM	  -­‐ Store in 1 ml eppendorfs and store at -18°C. 
 83 
Glutamate  0.147 g 
dH2O 5 ml 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6.3.1	  	  	  	  	  Stop	  Reaction	  solution	  
FeCl3.6H2O 11.0 g 
Trichloroacetic acid 4.0 g 
HCl concentrated 4.2 ml 
dH2O  200 ml 
 
 
 
  
 84 
Appendix	  B	  –	  Codon	  Optimised	  PfGS	  Sequence	  	  
Codon optimised DNA sequence for PfGS expression in Escherichia coli.  
Optimised  ATGAAGAGCGTTAGCTTTAGCAATAATGCCGAGCTGTATGAATATATCAAAGACAAA 
Native 1 ATGAAGTCCGTGAGTTTTTCAAATAATGCTGAGCTGTACGAGTACATAAAGGACAAA 
Translation  M  K  S  V  S  F  S  N  N  A  E  L  Y  E  Y  I  K  D  K   
 
Optimised  AAAAATGATGTGGAAATTGTGGCCTGCATTATTACCAATCTGCTGGGCACCTATTTC 
Native 58 AAGAATGATGTAGAAATAGTAGCTTGTATTATTACGAATTTATTAGGAACCTATTTT 
Translation  K  N  D  V  E  I  V  A  C  I  I  T  N  L  L  G  T  Y  F   
  
Optimised  AAATGCTTTTTTTATGTGAAAGAAATTACCCTGAATAAACTGGAAAGCGGCTTTAGC 
Native 115 AAGTGTTTTTTTTATGTAAAGGAGATTACATTAAATAAGTTAGAAAGTGGTTTTTCA 
Translation  K  C  F  F  Y  V  K  E  I  T  L  N  K  L  E  S  G  F  S   
 
Optimised  TTTGATGCAAGCAGCATCAAACTGTGTAGCGATACCGAAGTGAGCGATTTTTTTATT 
Native 172 TTTGACGCGTCTTCTATTAAACTATGTTCAGATACCGAAGTAAGTGATTTTTTTATT 
Translation  F  D  A  S  S  I  K  L  C  S  D  T  E  V  S  D  F  F  I   
 
Optimised  AAAGTGGATCATAGCACGTGTTATCTGGAAGAATGTGATGGCAAAAATATTCTGAAT 
Native 229 AAAGTAGATCATTCAACATGTTATTTGGAGGAATGTGATGGAAAGAATATATTAAAT 
Translation  K  V  D  H  S  T  C  Y  L  E  E  C  D  G  K  N  I  L  N   
 
Optimised  ATTATGTGCGATATTAAACGCTATAATGGCTTTGATTATTATAAATGCCCGCGTACC 
Native 286 ATCATGTGTGATATAAAGAGATATAATGGTTTTGATTATTATAAATGTCCAAGAACA 
Translation  I  M  C  D  I  K  R  Y  N  G  F  D  Y  Y  K  C  P  R  T   
 
Optimised  ATTCTGAAAAAAACCTGTGAATTTGTGAAAAATGAAGGCATTGCCGATAAAGTGTGC 
Native 343 ATATTAAAGAAAACATGTGAATTTGTTAAGAATGAAGGTATAGCAGATAAAGTTTGT 
Translation  I  L  K  K  T  C  E  F  V  K  N  E  G  I  A  D  K  V  C   
 
Optimised  ATTGGCAATGAACTGGAATTTTTTATCTTTGATAAAGTGAATTATTCCCTGGATGAA 
Native 400 ATTGGAAATGAATTGGAATTTTTTATATTTGATAAAGTAAATTATAGTTTAGATGAA 
Translation  I  G  N  E  L  E  F  F  I  F  D  K  V  N  Y  S  L  D  E   
 
Optimised  TATAATACCTATCTGAAAGTGTATGATCGCGAAAGCTTTAGCTGCAAAAATGATCTG 
Native 457 TATAATACATATTTAAAGGTTTATGATAGAGAATCATTTTCTTGTAAAAATGATTTA 
Translation  Y  N  T  Y  L  K  V  Y  D  R  E  S  F  S  C  K  N  D  L   
 
Optimised  AGCAGCATTTATGGTAATCATGTGGTGAATAAAGTGGAACCGCATAAAGATCATTTT 
Native 514 TCGAGTATTTATGGTAATCATGTTGTAAATAAAGTTGAACCACATAAAGATCATTTT 
Translation  S  S  I  Y  G  N  H  V  V  N  K  V  E  P  H  K  D  H  F   
 
Optimised  AATAATCCGAATAACGAATATCTGATTAATGATGACAGCAAAAAAGTGAAAAAAAAA 
Native 571 AATAATCCTAATAATGAATATTTAATTAATGATGATAGTAAAAAAGTAAAGAAAAAA 
Translation  N  N  P  N  N  E  Y  L  I  N  D  D  S  K  K  V  K  K  K   
  
Optimised  AGCGGCTATTTTACCACCGATCCGTATGATACCAGCAATATTATTAAACTGCGCATT 
Native 628 TCCGGTTATTTTACTACAGATCCATATGATACTTCTAATATAATTAAACTTAGAATA 
Translation  S  G  Y  F  T  T  D  P  Y  D  T  S  N  I  I  K  L  R  I   
  
Optimised  TGTCGTGCACTGAATGATATGAATATTAATGTGCAGCGCTATCATCACGAAGTTAGC 
Native 685 TGTAGAGCATTAAATGATATGAATATTAATGTACAAAGATATCATCATGAAGTTTCA 
Translation  C  R  A  L  N  D  M  N  I  N  V  Q  R  Y  H  H  E  V  S   
 
Optimised  ACCAGCCAGCATGAAATTAGCCTGAAATATTTTGATGCACTGACCAATGCAGATTTT 
Native 742 ACAAGTCAACATGAAATTTCTTTAAAATATTTTGATGCTCTAACAAATGCTGATTTT 
Translation  T  S  Q  H  E  I  S  L  K  Y  F  D  A  L  T  N  A  D  F   
  
Optimised  CTGCTGATTACCAAACAAATTATTAAAACCACCGTGAGCAGCTTTAATCGTACCGCA 
Native 799 TTACTTATTACAAAACAAATTATTAAAACAACAGTTAGCTCATTCAACAGAACAGCT 
Translation  L  L  I  T  K  Q  I  I  K  T  T  V  S  S  F  N  R  T  A   
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Optimised  ACCTTTATGCCGAAACCGCTGGTTAATGATAATGGTAATGGCCTGCATTGTAATATT 
Native 856 ACTTTTATGCCTAAACCTTTAGTTAATGATAATGGAAATGGTTTGCATTGTAATATA 
Translation  T  F  M  P  K  P  L  V  N  D  N  G  N  G  L  H  C  N  I   
  
Optimised  AGCCTGTGGAAAAATAACAAAAATATCTTTTATCATAATGATCCGAGCACCTTTTTT 
Native 913 TCTTTATGGAAAAATAATAAAAATATATTCTATCATAATGATCCTTCTACTTTCTTT 
Translation  S  L  W  K  N  N  K  N  I  F  Y  H  N  D  P  S  T  F  F   
 
Optimised  CTGAGCAAAGAAAGCTTTTATTTTATGTATGGCATTGTGAAACATGCAAAAGCACTG 
Native 970 TTATCAAAAGAATCTTTTTATTTTATGTATGGTATAGTTAAACATGCAAAAGCTTTA 
Translation  L  S  K  E  S  F  Y  F  M  Y  G  I  V  K  H  A  K  A  L   
 
Optimised  CAGGCATTTTGTAATGCAACCATGAATAGCTATAAACGTCTGGTTCCGGGTTTTGAA 
Native 1027 CAAGCCTTTTGTAACGCAACCATGAATTCATATAAAAGATTAGTACCAGGTTTTGAA 
Translation  Q  A  F  C  N  A  T  M  N  S  Y  K  R  L  V  P  G  F  E   
  
Optimised  ACCTGTCAGAAACTGTTTTATAGCTTTGGTAGCCGTAGCGCAGTTATTCGTCTGAGC 
Native 1084 ACTTGTCAAAAATTATTTTATTCATTTGGTTCAAGAAGTGCTGTTATCAGGTTATCT 
 Translation  T  C  Q  K  L  F  Y  S  F  G  S  R  S  A  V  I  R  L  S 
L    
Optimised  CTGATTAATTATAGCAATCCGAGCGAAAAACGTATTGAATTTCGTCTGCCGGATTGT 
Native 1141 TTGATTAACTACAGTAATCCATCAGAAAAAAGAATTGAATTTAGATTACCTGATTGT 
Translation  L  I  N  Y  S  N  P  S  E  K  R  I  E  F  R  L  P  D  C   
 
Optimised  GCAAATTCTCCGCATCTGGTTATGGCAGCAATTATTCTGGCAGGCTATGATGGCATT 
Native 1198 GCTAACTCACCACATCTAGTTATGGCTGCTATCATTTTGGCAGGTTATGATGGTATT 
Translation  A  N  S  P  H  L  V  M  A  A  I  I  L  A  G  Y  D  G  I   
 
Optimised  AAATCTAAAGAACAGCCGCTGGTTCCGTTTGAAAGCAAAGATAATCATTTTTATATC 
Native 1255 AAATCAAAAGAACAACCGCTGGTTCCATTTGAAAGTAAAGATAATCATTTCTACATT 
Translation  K  S  K  E  Q  P  L  V  P  F  E  S  K  D  N  H  F  Y  I   
  
Optimised  AGCAGCATCTTTTCTAAATATGTGCAGCATCCGGAAAATTTTAATATTCTGACCCAT 
Native 1312 TCAAGCATATTTTCGAAATATGTACAACACCCAGAAAATTTTAATATTCTTACTCAT 
Translation  S  S  I  F  S  K  Y  V  Q  H  P  E  N  F  N  I  L  T  H   
  
Optimised  GCCCTGGAAGGTTTTTCTAAATATGTGCAGCATCCGGAAAATTTTAATATTCTGACC
CAT Native 1369 GCCTTGGAAGGTTTTTCGAAATATGTACAACACCCAGAAAATTTTAATATTCTTACT
CAT Translation  A  L  E  G  Y  E  S  L  H  T  I  N  E  S  P  E  F  K  N   
  
Optimised  TTTTTCAAATGCGAAGAACCGCAGGGTATTAGCTTTAGCCTGGTTGAAAGCCTGGAT 
Native 1426 TTTTTTAAATGTGAAGAACCACAAGGTATATCTTTTTCTCTTGTCGAAAGTTTAGAT 
Translation  F  F  K  C  E  E  P  Q  G  I  S  F  S  L  V  E  S  L  D   
 
Optimised  GCACTGGAAAAAGATCATGCCTTTCTGACCGTGAATAATATTTTTACCGAAGAAATG 
Native 1483 GCTTTGGAAAAGGATCACGCATTTTTAACTGTAAATAATATTTTCACGGAGGAAATG 
Translation  A  L  E  K  D  H  A  F  L  T  V  N  N  I  F  T  E  E  M   
  
Optimised  ATTCAAGAATACATTAAATTTAAACGCGAAGAAATTGATGCCTATAATAAATACGTG 
Native 1540
8 
ATACAAGAATATATAAAGTTCAAAAGGGAAGAAATTGACGCATATAATAAATATGTT 
Translation  I  Q  E  Y  I  K  F  K  R  E  E  I  D  A  Y  N  K  Y  V   
 
Optimised  AATGCCTATGACTATCATCTGTACTACGAATGCTAA 
 Native 1597
8 
AACGCTTATGATTATCACTTATATTATGAATGTTAG (1632 bp) 
 Translation  N  A  Y  D  Y  H  L  Y  Y  E  C  *    
   The DNA PfGS sequence translates to 543 amino acid as indicated below. MKSVSFSNNAELYEYIKDKKNDVEIVACIITNLLGTYFKCFFYVKEITLNKLESGFSFDASSIKLCSDTEVSDFFIKVDHSTCYLEECDGKNILNIMCDIKRYNGFDYYKCPRTILKKTCEFVKNEGIADKVCIGNELEFFIFDKVNYSLDEYNTYLKVYDRESFSCKNDLSSIYGNHVVNKVEPHKDHFNNPNNEYLINDDSKKVKKKSGYFTTDPYDTSNIIKLRICRALNDMNINVQRYHHEVSTSQHEISLKYFDALTNADFLLITKQIIKTTVSSFNRTATFMPKPLVNDNGNGLHCNISLWKNNKNIFYHNDPSTFFLSKESFYFMYGIVKHAKALQAFCNATMNSYKRLVPGFETCQKLFYSFGSRSAVIRLSLINYSNPSEKRIEFRLPDCANSPHLVMAAIILAGYDGIKSKEQPLVPFESKDNHFYISSIFSKYVQHPENFNILTHALEGYESLHTINESPEFKNFFKCEEPQGISFSLVESLDALEKDHAFLTVNNIFTEEMIQEYIKFKREEIDAYNKYVNAYDYHLYYEC*	  (543aa)	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Appendix	  C	  -­‐	  Appion	  Graphical	  User	  Interface	  Screens	  
The following Appion GUI screens were used for computational processing of the data.  
1.	  	  	  Template	  Particle	  Picking	  (First	  Negative	  Stain	  Data	  Set)	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2.	  	  	  Stack	  Creation	  	  (First	  Negative	  Stain	  Data	  Set)	  
 
3.	  	  	  Reference	  Free	  Alignment	  (First	  Negative	  Stain	  Data	  Set)	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4.	  	  	  Particle	  Stack	  Creation	  (Second	  Negative	  Stain	  Data	  Set)	  
 
5.	  	  	  Reference	  Free	  Alignment	  (Second	  Negative	  Stain	  Data	  Set)	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6. Model	  Refinement	  (Second	  Negative	  Stain	  Data	  Set)
 90 
Appendix	  D	  –	  Glutamine	  Synthetase	  Sequences	  	  
The following sequences were used in multiple alignments to PfGS sequences. Conserved regions are highlighted. 
Organisms PDB depositions and associated sequences 
Salmonella typhimurium Depositions: 1989 -2GLS; 1994 -2LGS, 1LGR;   2000 -1F1H, 1F52, 1FPY 
SAEHVLTMLNEHEVKFVDLRFTDTKGKEQHVTIPAHQVNAEFFEEGKMFDGSSIGGWKGINESDMVLMPDASTAVIDPFFADSTLIIRCDILEPGTLQGYDRDPRSIAKRAEDYLRATGIADTVLFGPEPEFFLFDDIRFGASISGSHVAIDDIEG
AWNSSTKYEGGNKGHRPGVKGGYFPVPPVDSAQDIRSEMCLVMEQMGLVVEAHHHEVATAGQNEVATRFNTMTKKADEIQIYKYVVHNVAHRFGKTATFMPKPMFGDNGSGMHCHMSLAKNGTNLFSGDKYAGLSEQALYYIGGVIK
HAKAINALANPTTNSYKRLVPGYEAPVMLAYSARNRSASIRIPVVASPKARRIEVRFPDPAANPYLCFAALLMAGLDGIKNKIHPGEPMDKNLYDLPPEEAKEIPQVAGSLEEALNALDLDREFLKAGGVFTDEAIDAYIALRREEDDRVRMT
PHPVEFELYYSV (468 Amino Acids) 
Mycobacterium tuberculosis Depositions: 2001 -1HTO, 1HTQ; 2005 -2BVC; 2009 -2WGS, 2WHI; 2011 -3ZXR, 3ZXV 
TEKTPDDVFKLAKDEKVEYVDVRFCDLPGIMQHFTIPASAFDKSVFDDGLAFDGSSIRGFQSIHESDMLLLPDPETARIDPFRAAKTLNINFFVHDPFTLEPYSRDPRNIARKAENYLISTGIADTAYFGAEAEFYIFDSVSFDSRANGSFYEVDA
ISGWWNTGAATEADGSPNRGYKVRHKGGYFPVAPNDQYVDLRDKMLTNLINSGFILEKGHHEVGSGGQAEINYQFNSLLHAADDMQLYKYIIKNTAWQNGKTVTFMPKPLFGDNGSGMHCHQSLWKDGAPLMYDETGYAGLSDTARH
YIGGLLHHAPSLLAFTNPTVNSYKRLVPGYEAPINLVYSQRNRSACVRIPITGSNPKAKRLEFRSPDSSGNPYLAFSAMLMAGLDGIKNKIEPQAPVDKDLYELPPEEAASIPQTPTQLSDVIDRLEADHEYLTEGGVFTNDLIETWISFKRENEI
EPVNIRPHPYEFALYYDV (477Amino Acids) 
Note: Mycobacterium tuberculosis depositions since 2005 includes an histidine tag ;  MAHHHHHHG……. followed by above sequence (486 Amino Acids) 
Zea mays Depositions: 2005 -2D3A, 2D3B, 2D3C 
MACLTDLVNLNLSDTTEKIIAEYIWIGGSGMDLRSKARTLPGPVTDPSKLPKWNYDGSSTGQAPGEDSEVILYPQAIFKDPFRRGNNILVMCDCYTPAGEPIPTNKRYSAAKIFSSPEVAAEEPWYGIEQEYTLLQKDTNWPLGWPIGGFPGPQ
GPYYCGIGAEKSFGRDIVDAHYKACLYAGINISGINGEVMPGQWEFQVGPSVGISSGDQVWVARYILERITEIAGVVVTFDPKPIPGDWNGAGAHTNYSTESMRKEGGYEVIKAAIEKLKLRHKEHIAAYGEGNERRLTGRHETADINTFSW
GVANRGASVRVGRETEQNGKGYFEDRRPASNMDPYVVTSMIAETTIVWKP (356 Amino Acids) 
Homo sapiens Depositions: 2007 -2OJW, 2QC8 
MHHHHHHSSGVDLGTENLYFQSMASSHLNKGIKQVYMSLPQGEKVQAMYIWIDGTGEGLRCKTRTLDSEPKCVEELPEWNFDGSSTLQSEGSNSDMYLVPAAMFRDPFRKDPNKLVLCEVFKYNRRPAETNLRHTCKRIMDMVSNQHP
WFGMEQEYTLMGTDGHPFGWPSNGFPGPQGPYYCGVGADRAYGRDIVEAHYRACLYAGVKIAGTNAEVMPAQWEFQIGPCEGISMGDHLWVARFILHRVCEDFGVIATFDPKPIPGNWNGAGCHTNFSTKAMREENGLKYIEEAIEKLS
KRHQYHIRAYDPKGGLDNARRLTGFHETSNINDFSAGVANRSASIRIPRTVGQEKKGYFEDRRPSANCDPFSVTEALIRTCLLNETG (384 Amino Acids) 
Canis familiaris Depositions: 2007 -2UU7 
MATSASSHLNKGIKQVYMSLPQGEKVQAMYIWIDGTGEGLRCKTRTLDSEPKGVEELPEWNFDGSSTFQSEGSNSDMYLVPAAMFRDPFRKDPNKLVFCEVFKYNRKPAETNLRHTCKRIMDMVSNQHPWFGMEQEYTLMGTDGHPFG
WPSNGFPGPQGPYYCGVGADKAYGRDIVEAHYRACLYAGIKIAGTNAEVMPAQWEFQIGPCEGIDMGDHLWVARFILHRVCEDFGVIATFDPKPIPGNWNGAGCHTNFSTKAMREENGLKYIEESIEKLSKRHQYHIRAYDPKGGLDNAR
RLTGFHETSNINDFSAGVANRGASIRIPRTVGQEKKGYFEDRRPSANCDPFSVTEALIRTCLLNETGDEPFQYKNLEHHHHHH (381 Amino Acids) 
Saccharomyces cerevisiae Depositions: 2008 -3FKY 
MAEASIEKTQILQKYLELDQRGRIIAEYVWIDGTGNLRSKGRTLKKRITSIDQLPEWNFDGSSTNQAPGHDSDIYLKPVAYYPDPFRRGDNIVVLAACYNNDGTPNKFNHRHEAAKLFAAHKDEEIWFGLEQEYTLFDMYDDVYGWPKGGY
PAPQGPYYCGVGAGKVYARDMIEAHYRACLYAGLEISGINAEVMPSQWEFQVGPCTGIDMGDQLWMARYFLHRVAEEFGIKISFHPKPLKGDWNGAGCHANVSTKEMRQPGGTKYIEQAIEKLSKRHAEHIKLYGSDNDMRLTGRHETA
SMTAFSSGVANRGSSIRIPRSVAKEGYGYFEDRRPASNIDPYLVTGIMCETVCGAIDNADMTKEFERESS (370 Amino Acids) 
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Synechocystis sp	   Depositions: 2010 -3NG0 
MARTPQEVLKWIQDENIKIIDLKFIDTPGIWQHCSFYYDQLDENSFTEGIPFDGSSIRGWKAINESDMCMVPDPNTATIDPFCKEPTLSMICSIKEPRTGEWYNRDPRTIAAKAAEYLRGTGIADTVYFGPEAEFFLFDDIRFGQTENSSYYFADS
VEGRWNTGREEEGGNLGYKPGYKQGYFPVAPTDTAQDIRTEMLLTMAAFGVPIEKHHHEVASGGQNELGIKFDKLVNSADNLMIYKYVIKNVAKKYGKTVTFMPKPIFNDNGSGMHVHQSLWKDGQPLFAGDKYAGFSQMGLWYIGGI
LKHAPALLAFTNPTTNSYKRLVPGFEAPVNLAYSQGNRSASVRIPLSGGNPKAKRLEFRCPDATSNPYLAFAAMLCAGIDGIKNQIDPGEPLDVDIYDLSPEELAKIPSTPGSLEAALEALEKDHEFLTGTGVFSPDFVESWIEYKLDNEVNPM
RLRPHPYEFSLYYDC (473 Amino Acids) 
Bacteroides fragilis	   Depositions: 2010 -3O6X 
MSKMRFFALQELSNRKPLEITTPSNKLSDYYASHVFDRKKMQEYLPKEAYKAVVDATEKGTPISREMADLIANGMKSWAKSLNVTHYTHWFQPLTDGTAEKHDGFIEFGEDGEVIERFSGKLLIQQEPDASSFPNGGIRNTFEARGYTAWD
GSSPAFVVDTTLCIPTIFISYTGEALDYKTPLLKALAAVDKAATEVCQLFDKNITRVFTNLGWEQEYFLVDTSLYNARPDLRLTGRTLMGHSSAKDQQLEDHYFGSIPPRVTAFMKELEIECHKLGIPVKTRHNEVAPNQFELAPIFENCNLAN
DHNQLVMDLMKRIARKHHFAVLFHEKPYNGVNGSGKHNNWSLCTDTGINLFAPGKNPKGNMLFLTFLVNVLMMVHKNQDLLRASIMSAGNSHRLGANEAPPAILSIFLGSQLSATLDEIVRQVTNSKMTPEEKTTLKLGIGRIPEILLDTTD
RNRTSPFAFTGNRFEFRAAGSSANCAAAMIAINAAMANQLNEFKASVDKLMEEGIGKDEAIFRILKENIIASELIRFEGDGYSEEWKQEAARRGLTNICHVPEALMHYMDNQSRAVLIGERIFNETELACRLEVELEKYTMKVQIESRVLGDL
AINHIVPIAVSYQNRLLENLCRMKEIFSEEEYEVMSADRKELIKEISHRVSAIKVLVRDMTEARKVANHKENFKEKAFAYEETVRPYLESIRDHIDHLEMEIDDEIWPLPKYRELLFTK (729 Amino Acids) 
Plasmodium falciparum – gene of interest translated sequence from PlasmoDB genome website 
MKSVSFSNNAELYEYIKDKKNDVEIVACIITNLLGTYFKCFFYVKEITLNKLESGFSFDASSIKLCSDTEVSDFFIKVDHSTCYLEECDGKNILNIMCDIKRYNGFDYYKCPRTILKKTCEFVKNEGIADKVCIGNELEFFIFDKVNYSLDEYNTY
LKVYDRESFSCKNDLSSIYGNHVVNKVEPHKDHFNNPNNEYLINDDSKKVKKKSGYFTTDPYDTSNIIKLRICRALNDMNINVQRYHHEVSTSQHEISLKYFDALTNADFLLITKQIIKTTVSSFNRTATFMPKPLVNDNGNGLHCNISLWKN
NKNIFYHNDPSTFFLSKESFYFMYGIVKHAKALQAFCNATMNSYKRLVPGFETCQKLFYSFGSRSAVIRLSLINYSNPSEKRIEFRLPDCANSPHLVMAAIILAGYDGIKSKEQPLVPFESKDNHFYISSIFSKYVQHPENFNILTHALEGYESLHT
INESPEFKNFFKCEEPQGISFSLVESLDALEKDHAFLTVNNIFTEEMIQEYIKFKREEIDAYNKYVNAYDYHLYYEC (543 amino Acids) 
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